ENSG00000167323,STIM1,calcium signaling,store-operated calcium entry,cell proliferation,epithelial-to-mesenchymal transition,proliferation and survival,signaling pathway regulation
ENSG00000144935,TRPC1,cell migration,calcium signaling pathway,proliferation regulation,oncogenic process modulation,emt regulation,ion channel function
ENSG00000089250,NOS1,nitric oxide production,tumor progression,angiogenesis promotion,cell proliferation regulation,apoptosis modulation,prognostic marker
ENSG00000058668,ATP2B4,calcium signaling dysregulation,cell proliferation enhancement,overexpression in tumors,oncogenesis promoter,intracellular calcium regulation,protein expression alteration
ENSG00000069431,ABCC9,atp-sensitive potassium channels,dna repair mechanisms,cell cycle regulation,apoptosis resistance,cancer cell metabolism,genetic interaction with brca genes
ENSG00000187486,KCNJ11,ion channel regulation,cell proliferation,apoptosis dysregulation,genomic instability,therapeutic target,signaling pathway modulation
ENSG00000084754,HADHA,metabolic reprogramming,fatty acid oxidation,glycolytic shift,mitochondrial dysfunction,cellular metabolism,energy homeostasis
ENSG00000138029,HADHB,mitochondrial dysfunction,tumor metabolism,glycolysis upregulation,lactate production,therapeutic target,cancer prognosis
ENSG00000197265,GTF2E2,genomic instability,oncogene overexpression,transcriptional regulation,dna repair defect,genetic mutation hotspots,cell cycle progression
ENSG00000153767,GTF2E1,transcriptional dysregulation,enhancer hijacking,rna polymerase ii recruitment,protein-protein interactions,chromatin remodeling,apoptosis suppression
ENSG00000140307,GTF2A2,transcription initiation,pre-initiation complex assembly,cell proliferation regulation,genomic stability maintenance,biomarker potential,therapeutic target candidacy
ENSG00000165417,GTF2A1,transcription regulation,tumor progression,oncogene activation,cell proliferation,gene expression disruption,chromatin modification
ENSG00000162738,VANGL2,pcp pathway dysregulation,tumor progression promotion,emt regulation,cell migration and invasion enhancement,wnt/pcp signaling interaction,prognostic biomarker
ENSG00000274287,SCRIB,oncogene regulation,epithelial cell polarity,wnt/pcp pathway interaction,actin cytoskeleton regulation,tumor suppression,cancer progression
ENSG00000004975,DVL2,wnt signaling pathway,oncogenic transformation,epithelial-to-mesenchymal transition (emt),metastasis,resistance to chemotherapy,cell proliferation
ENSG00000102981,PARD6A,cell polarity regulation,epithelial-to-mesenchymal transition,pi3k/akt signaling pathway,cell migration and invasion,microtubule dynamics regulation,tumor progression
ENSG00000177885,GRB2,tyrosine kinase regulation,oncogenic signaling,cell proliferation,cell survival,signaling pathway activation,cancer driver gene status
ENSG00000109458,GAB1,rtk activation,cell proliferation enhancement,oncogene potential,scaffolding protein function,pro-oncogenic gene transcription,amplification or overexpression
ENSG00000146648,EGFR,epithelial-to-mesenchymal transition (emt),constitutive activation,oncogenic signaling pathway,cell proliferation,tumor progression,therapeutic target
ENSG00000138798,EGF,egf signaling pathway,cell proliferation,genomic instability,tumor progression,therapeutic target,metastasis
ENSG00000121879,PIK3CA,pi3k pathway activation,tumor progression,cell survival enhancement,oncogenic driver,growth factor signaling,metastatic potential
ENSG00000145675,PIK3R1,pi3k pathway regulation,constitutive activation,tumor progression driver,therapeutic target,cell survival enhancement,genomic profiling alteration
ENSG00000197122,SRC,tyrosine kinase activation,overexpression,oncogenic signaling,epithelial-to-mesenchymal transition,therapeutic resistance,cell migration and invasion
ENSG00000089159,PXN,tumor progression,cell adhesion disruption,metastasis promotion,protein-protein interaction,signaling pathway modulation,cytoskeletal regulation
ENSG00000137392,CLPS,tumor progression,cell migration,biomarker,apoptosis regulation,signaling pathway activation,extracellular matrix degradation
ENSG00000175535,PNLIP,lipid metabolism regulation,cell proliferation enhancement,tumor progression,signaling pathway modulation,protein interaction,genomic instability
ENSG00000078369,GNB1,g protein signaling pathway,oncogenic mutations,enhanced tumor growth,cell proliferation,increased metastasis,signaling pathway disruption
ENSG00000127928,GNGT1,cell proliferation,signaling regulation,oncogenesis,heterotrimeric g proteins,g protein subunit gamma transducing 1,regulatory component
ENSG00000198515,CNGA1,**
chloride ion transport,tumor progression,metastasis,epithelial integrity,cell signaling,channel activity 
**
ENSG00000070729,CNGB1,cell signaling pathway,tumor progression,cancer-associated mutations,genomic instability,proliferation regulation,calcium influx modulation
ENSG00000257365,FNTB,metabolic reprogramming,de novo fatty acid synthesis,tumor promotion,cancer cell metabolism,cell proliferation,prognostic marker
ENSG00000168522,FNTA,oncogenic properties,lipid metabolism regulation,fatty acid oxidation activation,metabolic reprogramming,therapeutic target,overexpression correlation
ENSG00000113522,RAD50,genomic instability,dna double-strand break repair,non-homologous end joining,mutation susceptibility,oncogenic process,cell cycle regulation
ENSG00000020922,MRE11,genomic instability,oncogenesis,double-strand break repair,nhej pathway,dna damage response,telomere maintenance
ENSG00000182481,KPNA2,nuclear import regulation,tumor progression facilitation,genomic instability promotion,dna repair mechanism alteration,onco-protein transport enhancement,poor prognosis indicator
ENSG00000104320,NBN,genomic instability,dna double-strand break repair,homologous recombination,nucleolar localization,tumor progression,oncogenic mutations
ENSG00000172977,KAT5,transcriptional dysregulation,chromatin remodeling,apoptosis resistance,cell cycle progression,genomic instability,tumor suppressor gene silencing
ENSG00000149311,ATM,genomic instability,defective dna repair,pi3k/akt pathway activation,tumor suppressor function,loss-of-function mutations,breast cancer susceptibility
ENSG00000009954,BAZ1B,chromatin remodeling,transcriptional regulation,dna repair defects,oncogene expression,genetic instability,therapeutic target
ENSG00000153147,SMARCA5,dna repair defects,gene expression regulation,chromatin remodeling complex,cell cycle disruption,tumor suppressor function,genomic instability
ENSG00000103275,UBE2I,genomic instability,dna damage response,protein regulation,ubiquitin-proteasome system,cell cycle control,oncogenesis
ENSG00000116030,SUMO1,dna damage response,genomic instability,apoptosis regulation,cell cycle progression,brca interaction,post-translational modification
ENSG00000169139,UBE2V2,cell cycle regulation,dna repair,ubiquitination pathway,tumor progression,oncogene role,protein degradation regulation
ENSG00000177889,UBE2N,genomic instability,protein stabilization,metastasis promotion,dna repair regulation,cell proliferation enhancement,ubiquitin-proteasome pathway
ENSG00000138376,BARD1,genomic instability,dna repair mechanisms,tumor suppressor role,cancer predisposition,genetic interactions,hdr pathway
ENSG00000012048,BRCA1,genomic instability,tumor suppressor activity,loss-of-function mutations,cell cycle regulation,apobec mutational signature,chromatin remodeling
ENSG00000188612,SUMO2,genomic instability,cellular response modulation,dna damage repair,protein stability regulation,tumor suppression,post-translational modification
ENSG00000225589,MDC1,dna repair modulation,oncogenic potential,cellular response activation,alternative repair mechanisms,tumor growth regulation,homologous recombination interaction
ENSG00000128731,HERC2,genomic stability,cell cycle regulation,oncogene,apoptosis regulation,microtubule dynamics,protein ubiquitination
ENSG00000164053,ATRIP,atm activation,homologous recombination,genome integrity maintenance,cell cycle regulation,dna damage response,kinase activity modulation
ENSG00000175054,ATR,genomic stability maintenance,dna damage response,cell cycle regulation,apoptosis induction,genetic mutation prevention,tumorigenesis promotion
ENSG00000111602,TIMELESS,genomic instability,cell cycle regulation,dna repair mechanisms,tumor suppressor function,transcriptional regulation,chromatin remodeling
ENSG00000075131,TIPIN,replication fork stabilization,genome stability maintenance,dna replication regulation,pcna complex interaction,cancer predisposition,genomic instability
ENSG00000163605,PPP4R2,pp4 dephosphorylation,cell cycle regulation,apoptosis suppression,dna repair regulation,metastasis enhancement,signaling pathway modulation
ENSG00000149923,PPP4C,pp2a regulation,oncogenic pathway activation,cell cycle progression,apoptosis evasion,p53 interaction,tumorigenesis modulation
ENSG00000108384,RAD51C,homologous recombination repair,genomic instability,dna double-strand breaks repair,tumor susceptibility,prognostic marker,genomic integrity maintenance
ENSG00000126215,XRCC3,dna repair mechanism,genomic stability,cell cycle regulation,tumor suppressor function,apoptosis regulation,chromosomal instability
ENSG00000197774,EME2,genomic instability,chromatin remodeling,tumor suppressor interaction,cell cycle regulation,dna repair,transcriptional control
ENSG00000172732,MUS81,genomic instability,dna repair dysfunction,replication fork processing,interstrand crosslink resolution,tumorigenesis facilitation,resistance to parp inhibition
ENSG00000154920,EME1,ubiquitin-proteasome system,dna damage response,genomic instability,tumor aggressiveness,oncogenic transformation,cell proliferation
ENSG00000139618,BRCA2,genomic instability,tumor suppressor function,homologous recombination repair,fanconi anemia/brca pathway,dna double-strand break repair,oxidative stress response
ENSG00000051180,RAD51,genomic instability,homologous recombination,dna double-strand break repair,oncogenic mutation prevention,cell cycle regulation,synaptic complex formation
ENSG00000175595,ERCC4,genomic instability,dna repair dysfunction,chromosomal aberrations,oncogenic transformation,homologous recombination repair,nucleotide excision repair
ENSG00000012061,ERCC1,dna repair mechanism,genomic stability maintenance,platinum-based chemotherapy resistance,oncogenic process driver,prognostic marker,therapeutic target
ENSG00000073050,XRCC1,genomic instability,dna damage response,base excision repair pathway,chemotherapy resistance,parp1 interaction,cell cycle regulation
ENSG00000005156,LIG3,genomic instability,oncogenic function,dna repair enzyme,tumor progression,nhej pathway,therapeutic resistance
ENSG00000196419,XRCC6,genomic instability,tumor suppressor function,dna repair regulation,gene expression regulation,cellular proliferation control,protein interaction dysfunction
ENSG00000079246,XRCC5,genomic instability,chromosomal rearrangements,dna repair mechanisms,tumor progression,oncogenesis promotion,genetic predisposition
ENSG00000152422,XRCC4,genomic stability,dna repair,non-homologous end joining,chromosomal instability,tumor progression,genome integrity
ENSG00000174405,LIG4,dna repair,genomic instability,cell survival,non-homologous end joining,double-strand break repair,tumor progression
ENSG00000049860,HEXB,genomic instability,cellular regulation,oncogenic processes,cell growth modulation,lysosomal function alteration,apoptosis inhibition
ENSG00000213614,HEXA,genomic instability,dna damage response,glycosphingolipid degradation,cell survival,oncogenic pathway,therapeutic target
ENSG00000151348,EXT2,genomic instability,dna repair pathway,nhej process,dna damage response,p53 activation,atm kinase activation
ENSG00000182197,EXT1,heparan sulfate synthesis,cell signaling regulation,tumor progression enhancement,metastasis facilitation,glycosaminoglycan modification,microenvironment interaction modulation
ENSG00000115904,SOS1,amplification driver mutations,ovarian mitogenic pathway activation,overexpression tumor suppressor regulation,ras/raf signaling activation,none,none
ENSG00000170312,CDK1,cell cycle regulation,constitutive activation,genetic instability,apoptosis suppression,protein kinase activity,oncogene activation
ENSG00000134057,CCNB1,cell cycle regulation,overexpression,chromosomal instability,aneuploidy,mitotic entry,prognostic marker
ENSG00000165494,PCF11,genomic instability,dna replication regulation,chromosome segregation,transcription regulation,homologous recombination repair,cancer driver gene
ENSG00000172409,CLP1,nucleolar rna metabolism impairment,genomic instability promotion,dna repair mechanisms disruption,oncogenic signaling pathway activation,tumor grade association,chemotherapy sensitivity modulation
ENSG00000187079,TEAD1,epithelial-to-mesenchymal transition,promoter interaction,transcription factor regulation,cell growth modulation,promotion of oncogenesis,binding to co-factors
ENSG00000137693,YAP1,hippo signaling pathway,tumor aggressiveness,oncogene overexpression,epithelial-to-mesenchymal transition,transcriptional coactivator,metastatic potential
ENSG00000074219,TEAD2,transcriptional regulation,epithelial-to-mesenchymal transition (emt),cell proliferation,oncogenic function,notch signaling pathway,metastasis
ENSG00000007866,TEAD3,hippo signaling pathway,tumor growth promotion,transcriptional regulation,oncogenic properties,yap1 interaction,cancer initiation
ENSG00000197905,TEAD4,hippo pathway regulation,transcriptional activation,cell proliferation,epithelial-to-mesenchymal transition,prognostic marker,genomic amplification
ENSG00000132964,CDK8,**

transcription regulation,cell proliferation,oncogene activation,wnt/β-catenin pathway modulation,pi3k/akt signaling interaction,therapeutic target
ENSG00000112237,CCNC,cell cycle regulation,oncogenic potential,genomic instability,dna repair pathways,transcriptional regulation,apoptosis suppression
ENSG00000101665,SMAD7,loss of function mutations,tumor suppressor,inhibitor of tgf-? pathway,epithelial-to-mesenchymal transition (emt),aberrant cell proliferation,genetic instability
ENSG00000157450,RNF111,oncogenic pathway regulation,ubiquitination process,tumor progression,metastasis,cell cycle regulation,apoptosis inhibition
ENSG00000284792,PTEN,tumor suppressor function,phosphatase activity,akt pathway inhibition,cell growth regulation,cancer mutation hotspot,genomic instability promotion
ENSG00000141510,TP53,cell cycle regulation,tumor suppression,genome maintenance,apoptosis induction,dna repair regulation,loss of function mutations
ENSG00000165699,TSC1,mtor signaling pathway,constitutive activation,tumor suppressor function loss,cell growth regulation,genomic instability,protein-protein interaction
ENSG00000103197,TSC2,mtor signaling,constitutive activation,loss of function mutations,tumor growth,metastasis,gtpase-activating protein
ENSG00000284194,SCO2,mitochondrial function alteration,ros production increase,cell cycle progression promotion,glycolytic shift induction,interaction with tfam/nrf1 regulation,p53 pathway disruption
ENSG00000048392,RRM2B,cellular metabolism,oncogene upregulation,energy homeostasis,ribosome recycling,mrna stability,tumor aggressiveness
ENSG00000135423,GLS2,glutamine metabolism,oncogenic processes,chemoresistance development,tumor growth promotion,metabolic adaptation,cancer cell survival
ENSG00000146674,IGFBP3,tumor suppressor function,loss of function mutations,pi3k/akt pathway regulation,cell growth inhibition,apoptosis promotion,igf binding activity
ENSG00000141682,PMAIP1,apoptosis regulation,tumor suppression,cell cycle arrest,genomic stabilization,promyelocytic leukemia protein interaction,mitochondrial outer membrane permeabilization
ENSG00000015475,BID,apoptosis regulation,caspase activation,bh3-only protein,cell survival inhibition,tumor growth promotion,pro-apoptotic function
ENSG00000120471,TP53AIP1,p53 regulation,cell proliferation,dna damage response,oncogenic properties,apoptosis inhibition,tumor suppressor
ENSG00000197050,ZNF420,zinc finger binding,epithelial-to-mesenchymal transition regulation,cell migration and invasion,oncogenic overexpression,gene expression modulation,chromatin remodeling activity
ENSG00000115107,STEAP3,iron regulation,metalloreductase activity,tumor progression,biomarker potential,hypoxia adaptation,oxidative stress resistance
ENSG00000104765,BNIP3L,mitochondrial regulation,gene dysregulation,tumor growth promotion,energy metabolism modulation,angiogenesis regulation,hif-1α pathway interaction
ENSG00000170855,TRIAP1,genomic instability,dna damage response,cell cycle regulation,cell proliferation,tumor suppressor function,co-factor in tumorigenesis
ENSG00000042286,AIFM2,genomic instability,pi3k/akt pathway activation,oncogenic potential,tumor progression,cell proliferation,mitochondrial function
ENSG00000164938,TP53INP1,cell cycle regulation,tumor suppressor function,dna damage response,genomic instability,chromosomal alterations,oncogenic process
ENSG00000120868,APAF1,apoptotic pathway dysregulation,dna damage response,oncogene activation,genetic instability,cell survival promotion,cancer progression facilitation
ENSG00000177595,PIDD1,apoptosis induction,cell proliferation inhibition,dna damage response,pro-apoptotic protein function,tumor suppression,genomic stability maintenance
ENSG00000169372,CRADD,apoptosis regulation,pro-apoptotic activity,tumor suppression,downregulated expression,epigenetic modifications,biomarker potential
ENSG00000091106,NLRC4,nlrc4 inflammasome,tumor-suppressive properties,inflammation regulation,apoptosis activation,autophagy promotion,cell death induction
ENSG00000138794,CASP6,apoptosis regulation,inflammation modulation,tumor progression,metastasis promotion,immune response modulation,cell death pathways
ENSG00000003400,CASP10,apoptosis regulation,extrinsic pathway activation,proteolytic activity,intrinsic pathway modulation,tumor resistance,oncogenic potential
ENSG00000104419,NDRG1,tumor suppressor function,cellular differentiation regulation,anti-proliferative properties,metastasis inhibition,apoptosis regulation,dna repair modulation
ENSG00000281449,BCL2L14,apoptosis regulation,mitochondrial outer membrane permeabilization,programmed cell death,tumor suppressor function,genomic instability,chemotherapy resistance
ENSG00000089685,BIRC5,apoptosis inhibition,oncogene activation,genomic instability,dna damage repair,cell survival promotion,tumor progression facilitation
ENSG00000113916,BCL6,bcl6 mediated repression,cell survival enhancement,chromatin remodeling,epigenetic regulation,histone modification,oncogene activation
ENSG00000161642,ZNF385A,transcription factor regulation,cell cycle progression disruption,tumor suppressor function loss,apoptosis resistance enhancement,oncogene overexpression,genomic location alteration
ENSG00000116017,ARID3A,epigenetic regulation,chromatin remodeling,dna repair deficiency,genomic instability,transcriptional activation,cell cycle dysregulation
ENSG00000165891,E2F7,cell cycle regulation,tumor suppression,apoptosis induction,dna binding activity,transcriptional repression,genomic stability maintenance
ENSG00000129173,E2F8,cell cycle regulation,tumor suppressor function,oncogene activation,transcriptional regulation,epithelial-to-mesenchymal transition (emt),genomic overexpression
ENSG00000116717,GADD45A,cell cycle regulation,apoptosis induction,tumor suppression,genomic instability,dna damage repair,cyclin-dependent kinase inhibition
ENSG00000087586,AURKA,genomic instability,cell proliferation,constitutive activation,therapeutic target,mitotic regulation,apoptosis suppression
ENSG00000132646,PCNA,dna replication regulation,gene amplification,cell proliferation enhancement,genetic instability induction,chromatin remodeling facilitation,tumor suppressor inhibition
ENSG00000087088,BAX,apoptosis regulation,mitochondrial outer membrane permeabilization,tumor suppressor function,dna repair regulation,cell survival regulation,genomic stability maintenance
ENSG00000175793,SFN,anti-apoptotic function,tumorigenesis regulator,apoptosis inhibitor,oncogenic potential enhancer,cell survival mediator,resistance to chemotherapy
ENSG00000145632,PLK2,cell cycle regulation,mitotic entry progression,chromosome segregation,genomic instability,tumor progression,therapeutic target
ENSG00000173846,PLK3,genomic instability,dna damage response,cell proliferation enhancement,oncogenic overexpression,mitotic progression facilitation,centrosome maturation regulation
ENSG00000102760,RGCC,genomic instability,epigenetic regulation,chromatin remodeling,tumor progression,cell cycle regulation,dna damage response
ENSG00000118495,PLAGL1,cellular proliferation,transcriptional regulation,epigenetic regulation,oncogenic function,chromatin remodeling,tumor progression
ENSG00000115966,ATF2,transcriptional regulation,cell cycle progression,oncogenic signaling,chromatin remodeling,apoptosis suppression,prognostic marker
ENSG00000177606,JUN,cell cycle progression,constitutive activation,apoptosis resistance,transcriptional regulation,prognostic marker,metastasis promotion
ENSG00000170345,FOS,oncogene activation,genetic amplification,apoptosis resistance,cell proliferation promotion,tumor aggressiveness,angiogenesis facilitation
ENSG00000122512,PMS2,epigenetic regulation,genomic instability,dna repair deficiency,cell cycle regulation,apoptosis modulation,histone modification
ENSG00000076242,MLH1,genetic instability,tumor suppressor,deficient dna repair,increased mutation rate,mismatch repair,genomic alterations
ENSG00000158169,FANCC,dna repair mechanisms,genomic instability,interstrand crosslink (icl) repair,fanconi anemia pathway,cell cycle regulation,tumor suppressor
ENSG00000134574,DDB2,genomic instability,dna repair deficiency,checkpoint regulation failure,chromatin remodeling disruption,protein-protein interaction defects,cell cycle regulation impairment
ENSG00000057657,PRDM1,tumor suppressor function,immune response regulation,transcriptional regulator,epigenetic regulation,cell cycle regulation,apoptosis modulation
ENSG00000135679,MDM2,p53 degradation,dna damage response,cell cycle regulation,oncogenic response,prognostic marker,ubiquitin ligase activity
ENSG00000198625,MDM4,p53 inhibition,tumor suppressor dysfunction,cell cycle progression,apoptosis resistance,genomic instability,oncogenic function
ENSG00000113328,CCNG1,genomic instability,oncogene activation,cell cycle dysregulation,tumor progression,metastasis promotion,protein-protein interaction
ENSG00000064393,HIPK2,apoptosis regulation,tumor suppressor function,cell cycle modulation,dna damage response,protein phosphorylation,genomic stability maintenance
ENSG00000127445,PIN1,chromatin remodeling,epigenetic regulation,genomic instability,oncogenic potential,protein-protein interaction,tumor suppressor inactivation
ENSG00000163349,HIPK1,tumor suppressor,genomic instability,cell proliferation,angiogenesis,pi3k/akt/mtor pathway,p53 regulation
ENSG00000149136,SSRP1,**
ssrp1,genomic instability,rna splicing regulation,dna repair mechanism,tumor suppressor function,transcriptional regulation
**
ENSG00000092201,SUPT16H,chromatin remodeling,transcriptional regulation,overexpression,tumor progression,biomarker potential,epigenetic modulation
ENSG00000101266,CSNK2A1,cell cycle regulation,genomic instability,dna repair mechanisms,cell growth enhancement,apoptosis suppression,signaling pathway activation
ENSG00000070770,CSNK2A2,casein kinase 2 activation,constitutive activation,cell cycle regulation,oncogenic processes,tumor progression,apoptosis suppression
ENSG00000088325,TPX2,microtubule regulation,spindle assembly,oncogene activation,genomic instability,aneuploidy induction,tumor suppressor bypassing
ENSG00000188976,NOC2L,cell cycle regulation,genomic instability,mitotic progression,protein-protein interaction,ubiquitination,oncogenic overexpression
ENSG00000176749,CDK5R1,cyclin-dependent kinase activation,overexpression,oncogenic potential,cell proliferation enhancement,neuronal differentiation regulation,apoptosis inhibition
ENSG00000164885,CDK5,cell cycle regulation,constitutive activation,genomic instability,oncogenic processes,therapeutic target,protein kinase activation
ENSG00000152192,POU4F1,transcription factor regulation,tumor progression,cell proliferation pathway,epithelial-to-mesenchymal transition,mutational activation,neuronal differentiation
ENSG00000151615,POU4F2,cell cycle regulation,genomic instability,transcriptional regulation,dna repair mechanisms,oncogenic signaling,poor prognosis marker
ENSG00000172530,BANP,dna damage response,transcription regulation,genomic instability,cell proliferation,oncogene,chromatin remodeling
ENSG00000025293,PHF20,chromatin remodeling,transcriptional regulation,oncogene function,epigenetic modification,histone interaction,tumor progression
ENSG00000185513,L3MBTL1,chromatin remodeling,tumor suppression,dna damage response,genome instability,ubiquitin ligase activity,epigenetic regulation
ENSG00000238134,EHMT2,chromatin regulation,epigenetic mark maintenance,histone methylation,tumor suppressor gene suppression,oncogenic transformation,poor prognosis marker
ENSG00000181090,EHMT1,h3k9 methylation,epigenetic regulation,genomic stability,tumor suppression,cell proliferation,chromatin remodeling
ENSG00000137203,TFAP2A,transcription factor activation,oncogenic driver,cell proliferation regulation,estrogen receptor signaling modulation,pi3k/akt pathway interaction,tumor suppressor dysfunction
ENSG00000124795,DEK,chromatin remodeling,oncogenic activity,cell proliferation,therapy resistance,metastatic potential,dna damage response
ENSG00000087510,TFAP2C,er signaling pathway modulation,gene amplification,chromatin remodeling,apoptosis suppression,cell proliferation enhancement,tumor suppressor regulation
ENSG00000186153,WWOX,tumor suppressor function,genomic instability,apoptosis regulation,cell cycle regulation,pi3k/akt/mtor pathway interaction,e3 ubiquitin ligase activity
ENSG00000008196,TFAP2B,tumor promoter,transcription factor activation,cell proliferation regulation,oncogene function,genetic variation impact,dna binding affinity
ENSG00000127337,YEATS4,chromatin remodeling,transcriptional regulation,genome stability maintenance,chromatin acetylation,histone modification,cancer progression
ENSG00000091831,ESR1,estrogen receptor activation,constitutive activation,amplification/mutation,tumor progression,therapeutic target,genomic profiling
ENSG00000156802,ATAD2,chromatin remodeling,epigenetic modifications,gene expression regulation,genomic instability,transcriptional activation,tumor aggressiveness
ENSG00000112715,VEGFA,angiogenesis,tumor progression,metastasis resistance,angiogenic switch,vascular permeability,pro-tumorigenic signal
ENSG00000163235,TGFA,epithelial-to-mesenchymal transition (emt),cross-linking enzyme activity,vascular remodeling,angiogenesis promoter,cancer cell migration,integrin interaction
ENSG00000124762,CDKN1A,cell cycle regulation,tumor suppressor function,dna damage response,apoptosis promotion,genomic instability,promoter methylation
ENSG00000159216,RUNX1,oncogenic transcription factor,dysregulated gene expression,apoptosis inhibition,cell proliferation driver,tumor suppressor interactions,hematopoiesis regulator
ENSG00000078900,TP73,tumor suppressor activity,loss-of-function mutation,genomic instability,apoptosis regulation,cell cycle modulation,dna damage response
ENSG00000179588,ZFPM1,epithelial-to-mesenchymal transition regulation,tumor suppressor function,transcription factor activity,cell adhesion modulation,metastasis inhibition,wnt/β-catenin pathway interaction
ENSG00000102145,GATA1,transcription factor regulation,tumor progression,cell proliferation,gene amplification,dna repair disruption,hematopoiesis dysregulation
ENSG00000143387,CTSK,tumor progression,proteolytic activity,cell invasion,apoptosis evasion,oncogene,genomic instability
ENSG00000197641,SERPINB13,cellular proliferation inhibition,tumor suppressor function,proteolytic regulation,immune response modulation,biomarker potential,signaling pathway interaction
ENSG00000110092,CCND1,oncogenic driver,cell cycle progression,cyclin-dependent kinase interaction,genomic instability,epithelial-to-mesenchymal transition (emt),transcriptional regulation
ENSG00000135446,CDK4,cell cycle regulation,g1 phase progression,proliferation,tumor growth,amplification events,therapeutic target
ENSG00000173153,ESRRA,epigenetic regulation,tumor progression,estrogen signaling,transcriptional activation,oncogene regulation,histone modification
ENSG00000109819,PPARGC1A,pparγ transcription factor activation,constitutive overexpression,metabolic reprogramming,cell proliferation promotion,dna repair dysfunction,therapeutic target discovery
ENSG00000122691,TWIST1,epithelial-to-mesenchymal transition (emt),transcription factor activity,cell proliferation regulation,metastasis promotion,tumor suppressor gene inhibition,gene expression regulation
ENSG00000124813,RUNX2,genomic instability,transcription factor dysfunction,epithelial tissue maintenance,cell proliferation deregulation,apoptosis suppression,epithelial-to-mesenchymal transition
ENSG00000109705,NKX3-2,tumor suppressor activity,regulatory interactions,cell proliferation modulation,biomarker potential,apoptosis induction,metastasis suppression
ENSG00000120149,MSX2,wnt/β-catenin pathway,epithelial-to-mesenchymal transition (emt),oncogene,transcription factor,tumor aggressiveness,proliferation regulation
ENSG00000141646,SMAD4,tumor suppressor function,loss of heterozygosity,bmp signaling pathway,cell proliferation regulation,tgf-β receptor interaction,epithelial polarity maintenance
ENSG00000170365,SMAD1,tgf-beta signaling pathway,bmp branch regulation,dual function role,oncogenic transformation,apoptosis inhibition,cell proliferation regulation
ENSG00000020633,RUNX3,loss of function,downregulated transcription factor,cell proliferation regulation,apoptosis modulation,emt regulation,wnt/β-catenin pathway interaction
ENSG00000166949,SMAD3,tgf-β pathway regulation,oncogenic transformation,tumor progression,transcriptional regulation,mutations leading to oncogenesis,epigenetic dysregulation
ENSG00000198176,TFDP1,e2f/co-factor interaction,cell cycle regulation,transcriptional control,overexpression,apoptosis suppression,cyclin regulation
ENSG00000169016,E2F6,tumor suppression,cell cycle regulation,gene repression,cell proliferation inhibition,dna replication control,loss of function mutations
ENSG00000114126,TFDP2,cell cycle regulation,e2f-dp complex,dna replication,transcriptional modulation,oncogenic potential,aggressive tumor behavior
ENSG00000174197,MGA,cell cycle regulation,tumor suppressor function,chromosomal instability,aneuploidy,genomic stability maintenance,dna repair mechanism
ENSG00000125952,MAX,transcriptional regulation,cancer driver,heterodimer formation,nuclear localization,cell cycle progression,proliferation and survival promotion
ENSG00000213246,SUPT4H1,chromatin remodeling,transcriptional regulation,oncogenesis,gene expression modulation,rna polymerase ii recruitment,transcriptional activation
ENSG00000196235,SUPT5H,dna repair mechanisms,chromatin remodeling,transcription elongation factor,cellular proliferation regulation,tumor progression marker,prognostic significance
ENSG00000103363,ELOB,ribosome biogenesis,regulation of protein synthesis,cellular stress response,tumor progression,genomic instability,cellular proliferation
ENSG00000154582,ELOC,genomic instability,oncogenic process,tumor progression,cell cycle regulation,protein degradation,ubiquitination pathway
ENSG00000125651,GTF2F1,genomic instability,dna repair deficiency,cell cycle disruption,tumor suppressor function,transcriptional regulation,cancer susceptibility
ENSG00000188342,GTF2F2,transcriptional regulation,cell cycle regulation,apoptosis,dna repair,chromatin remodeling,transcription factor activity
ENSG00000114503,NCBP2,transcription regulation,mrna processing,cell survival,oncogenic role,protein-protein interactions,cancer prognosis marker
ENSG00000136937,NCBP1,pi3k/akt signaling,prognostic marker,oncogenic process regulation,cell growth modulation,metabolic regulation,cancer progression
ENSG00000224748,TAP1,immunoevasion,antigen presentation disruption,cellular transport regulation,oncogene dysregulation,cancer immunotherapy target,cell membrane interaction
ENSG00000223481,TAP2,antigen processing,immune evasion,protein degradation,ubiquitin-proteasome pathway,mhc class i antigen presentation,cancer prognosis
ENSG00000166126,AMN,cancer cell migration,cell adhesion regulation,cytoplasmic protein interaction,tumor aggressiveness,oncogene activation,neural differentiation defect
ENSG00000107611,CUBN,cell migration,pi3k/akt signaling pathway,protein-protein interaction,tumor progression,dysregulation,gene expression modulation
ENSG00000146085,MMUT,genetic instability,dna repair deficiency,oxidative dna damage,tumor suppression,cancer risk factor,gene expression alteration
ENSG00000151611,MMAA,mitochondrial dysfunction,oncogenic driver,mitochondrial biogenesis regulation,tumor microenvironment modulation,cancer cell proliferation,immune evasion
ENSG00000117560,FASLG,apoptosis regulation,tumor suppression,extrinsic pathway activation,cell death promotion,cancer development disruption,apoptotic signaling
ENSG00000026103,FAS,apoptosis regulation,immune modulation,tumor microenvironment disruption,cell survival promotion,tissue homeostasis disruption,dysregulated expression levels
ENSG00000156735,BAG4,cell cycle regulation,apoptosis resistance,autophagy modulation,pi3k/akt pathway interaction,cell adhesion facilitation,protein folding regulation
ENSG00000067182,TNFRSF1A,tumor necrosis factor receptor signaling,nf-κb pathway activation,cell migration promotion,immune evasion mechanisms,cancer cell survival enhancement,therapeutic target development
ENSG00000230108,TNF,angiogenesis promotion,inflammation induction,immune suppression,cell proliferation enhancement,tumor progression facilitation,nf-κb activation
ENSG00000106052,TAX1BP1,nf-κb signaling pathway disruption,tumor suppressor function loss,dna damage response,genomic instability promotion,cell growth regulation impairment,protein-protein interaction cruciality
ENSG00000118503,TNFAIP3,loss of tumor suppressor function,nf-κb activation,inflammatory response regulation,cell survival enhancement,oncogenesis promotion,genomic instability
ENSG00000104689,TNFRSF10A,apoptosis induction,protein-protein interaction,tumor progression resistance,nf-kb modulation,cell survival regulation,jak/stat activation
ENSG00000173530,TNFRSF10D,apoptosis regulation,trail interaction,caspase activation,tumor progression,immune modulation,cell survival
ENSG00000120889,TNFRSF10B,apoptosis induction,tumor suppressor function,receptor-ligand interactions,cell survival regulation,downregulation in cancer,programmed cell death pathway
ENSG00000134259,NGF,neurotrophic signaling,cell survival,angiogenesis promotion,tumor progression facilitation,receptor activation,mitogenic activity
ENSG00000064300,NGFR,cancer stem cells,cell proliferation,tumor necrosis factor signaling,pi3k/akt pathway activation,promotes cellular migration,poor prognosis biomarker
ENSG00000184216,IRAK1,nf-κb pathway activation,tumor progression,immune evasion,metastasis promotion,emt phenotype association,phosphorylation and activation
ENSG00000172936,MYD88,nf-κb pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,genomic instability
ENSG00000109320,NFKB1,nf-κb activation,constitutive transcription,epithelial-to-mesenchymal transition,immune evasion,oncogenic signaling pathway,tumor progression
ENSG00000173039,RELA,nf-kappa b activation,oncogenic activity,tumor progression,cell proliferation regulation,apoptosis suppression,transcriptional regulation
ENSG00000119048,UBE2B,protein degradation regulation,oncogenic protein stabilization,cell cycle progression modulation,ubiquitination pathway dysregulation,e3 ligase interaction,tumor suppressor modification
ENSG00000070950,RAD18,dna repair,translesion synthesis,genetic instability,tumor progression,oncogene potential,protein degradation
ENSG00000114742,WDR48,genomic instability,homologous recombination repair,dna damage response,tumor progression,oncogene function,cellular machinery regulation
ENSG00000162607,USP1,dna repair defects,cell cycle deregulation,tumor suppressor dysfunction,genomic instability,oncogenic driver,ubiquitination dysregulation
ENSG00000009413,REV3L,genomic instability,translesion synthesis error-prone,tumor progression driver,dna polymerase activity,genetic mutations accumulation,therapeutic target potential
ENSG00000116670,MAD2L2,genomic instability,disrupted cell cycle regulation,oncogenic signaling pathway activation,dna damage repair regulation,cell proliferation promotion,prognostic biomarker candidate
ENSG00000163743,RCHY1,epigenetic regulation,chromatin modification,histone family protein,dna repair mechanisms,gene expression regulation,transcriptional regulation
ENSG00000170734,POLH,genomic instability,dna repair mechanism,tumor suppressor,error-prone dna synthesis,mutational accumulation,uv-induced damage response
ENSG00000121060,TRIM25,epigenetic silencing,ifn-i signaling,tumor suppressor function,cell proliferation enhancement,chemotherapy resistance,protein-protein interaction
ENSG00000156587,UBE2L6,genomic stability maintenance,cell cycle regulation,transcriptional modulation,protein degradation facilitation,ubiquitination pathway involvement,cancer development contribution
ENSG00000182179,UBA7,genomic instability,ubiquitination pathway disruption,cell cycle regulation,dna repair mechanism,protein degradation dysregulation,cancer driver gene status
ENSG00000187608,ISG15,genomic instability,cell proliferation regulation,apoptosis inhibition,protein modification,immune response modulation,oncogenic potential
ENSG00000184900,SUMO3,cellular process regulation,gene expression modulation,protein stability modification,tumor progression marker,biomarker significance,dna damage response alteration
ENSG00000131944,FAAP24,genomic instability,mutation hotspot,tumor suppressor function,dna repair mechanism,fanconi anemia pathway interaction,cancer predisposition
ENSG00000187790,FANCM,genomic instability,dna repair deficiency,increased cancer risk,homologous recombination,sister chromatid exchange,tumor suppressor function
ENSG00000169689,CENPX,genomic instability,chromosomal segregation,centrosome organization,tumor progression,therapeutic target,mitotic regulation
ENSG00000175279,CENPS,cell proliferation,genomic instability,tumor progression,chromosome segregation,spindle checkpoint regulation,overexpression
ENSG00000140525,FANCI,genomic instability,dna damage repair,tumor progression,therapeutic target,cellular response,protein interaction
ENSG00000144554,FANCD2,genomic instability,homologous recombination,dna repair mechanisms,cell cycle regulation,tumor suppression,non-homologous end joining
ENSG00000175198,PCCA,cellular proliferation,enzyme regulation,protein processing,triglyceride degradation,tumor progression,pancreatic enzyme activity
ENSG00000114054,PCCB,mitochondrial function,energy metabolism regulation,glycolysis promotion,cellular respiration,metabolic adaptation,genetic variation
ENSG00000275300,MCCC2,mitochondrial function,energy production,leucine catabolism,branched-chain amino acid regulation,tumor metabolism,genomic instability
ENSG00000078070,MCCC1,mitochondrial enzyme regulation,tumor suppressor function,branched-chain amino acid metabolism,energy metabolism disruption,apoptosis induction,oncogenic process promotion
ENSG00000175505,CLCF1,angiogenesis,epithelial-to-mesenchymal transition,oncogene function,poor clinical outcomes,therapeutic target,biomarker expression
ENSG00000006016,CRLF1,oncogene,cell proliferation,signaling pathway activation,immune evasion,tumor metastasis,prognostic marker
ENSG00000130175,PRKCSH,chaperone function,protein stability,cell growth regulation,tumor progression,oncogene stabilization,breast cancer aggressiveness
ENSG00000089597,GANAB,lysosomal degradation,sphingolipid metabolism,oncogenic transformation,cell migration,therapeutic target,pi3k/akt pathway interaction
ENSG00000179218,CALR,aberrant signaling pathways,cell proliferation,cell adhesion,molecular dysregulation,genetic instability,protein misfolding
ENSG00000283777,CANX,cellular chaperoning,endoplasmic reticulum function,glycoprotein folding,cell cycle regulation,dna repair pathway,chemotherapy resistance
ENSG00000182185,RAD51B,genomic instability,tumor suppressor function,dna double-strand break repair,homologous recombination,genetic instability,genome maintenance
ENSG00000243678,NME2,genomic instability,epithelial-to-mesenchymal transition,oncogenic transcription factors,cell proliferation,apoptosis evasion,dna repair mechanisms
ENSG00000239672,NME1,tumor suppressor function,cancer cell proliferation,pi3k/akt pathway regulation,apoptosis resistance,prognostic marker,gene silencing
ENSG00000157500,APPL1,cellular growth regulation,metabolic reprogramming,tumor suppression,loss of function mutations,apoptosis evasion,insulin signaling pathway
ENSG00000187323,DCC,epithelial polarity loss,cell adhesion disruption,apoptosis suppression,tumor suppressor function,cellular invasion enhancement,signaling pathway regulation
ENSG00000179222,MAGED1,cell cycle regulation,apoptosis inhibition,tumor progression,p53 interaction,immune evasion,genomic instability
ENSG00000113763,UNC5A,netrin receptor signaling pathway,tumor suppressor activity,cell migration regulation,axon guidance regulation,apoptosis promotion,pi3k/akt pathway inhibition
ENSG00000221823,PPP3R1,cell cycle regulation,constitutive activation,oncogenic signaling pathway,epithelial-to-mesenchymal transition (emt),nf-κb transcription factor,cancer cell invasion
ENSG00000120910,PPP3CC,calcium-dependent signaling pathway,tumor suppression,nfat transcription factor regulation,cellular proliferation,apoptosis regulation,cancer progression
ENSG00000171791,BCL2,apoptosis regulation,anti-apoptotic function,cell survival promotion,tumor progression driver,therapeutic target resistance,gene expression regulation
ENSG00000002330,BAD,apoptosis regulation,cell survival modulation,pro-apoptotic protein function,tumor suppression,genomic stability maintenance,mitochondrial outer membrane permeabilization
ENSG00000030110,BAK1,apoptosis dysregulation,genomic instability,mitochondrial outer membrane permeabilization,oncogenic transformation,pro-apoptotic function,tumorigenesis
ENSG00000172115,CYCS,apoptosis suppression,cell survival enhancement,genomic instability promotion,mitochondrial function alteration,prognostic biomarker potential,tumor progression facilitation
ENSG00000101966,XIAP,tumor suppressor deficiency,apoptosis inhibition,genomic instability,therapeutic target,cell survival promotion,protein-protein interaction
ENSG00000164305,CASP3,apoptosis,cancer cell survival,cell death regulation,chemotherapy resistance,caspase activation,protein-protein interactions
ENSG00000165806,CASP7,apoptosis regulation,tumor progression,genomic instability,cell death promotion,rna cleavage,protein activation
ENSG00000132906,CASP9,apoptosis regulation,tumor suppression,programmed cell death,dna damage response,proteolytic cleavage,cytokine activation
ENSG00000184047,DIABLO,apoptosis regulation,cell death promotion,iap inhibition,oncogenic activity,tumor aggressiveness,protein-protein interactions
ENSG00000169598,DFFB,apoptosis modulation,cell death regulation,dna fragmentation,genomic instability,oncogenic activity,therapeutic target
ENSG00000160049,DFFA,dna fragmentation,apoptosis regulation,genomic integrity maintenance,cellular response modulation,endonuclease complex formation,protein interaction
ENSG00000114030,KPNA1,genomic instability,nuclear import/export regulation,oncoprotein transport,cell cycle progression modulation,apoptosis suppression,poor prognosis marker
ENSG00000108424,KPNB1,importin function,dysregulated gene expression,altered subcellular localization,nuclear transport regulation,cell cycle disruption,apoptosis suppression
ENSG00000180370,PAK2,genomic instability,pi3k/akt pathway activation,metastasis promoter,cell migration regulation,tumor progression enhancer,dna damage response modulation
ENSG00000071205,ARHGAP10,loss of expression,downregulation,regulatory mechanism,tumor progression,microtubule dynamics,rho gap activity
ENSG00000137275,RIPK1,apoptosis regulation,nf-κb signaling pathway,necroptosis,inflammation modulation,cell survival enhancement,therapeutic target
ENSG00000129465,RIPK3,apoptosis regulation,necroptotic pathway activation,pro-inflammatory mediator release,oncogenic process promotion,tumor growth facilitation,cellular membrane disruption
ENSG00000131979,GCH1,dna repair dysfunction,genomic instability,oxidative stress,protein synthesis dysregulation,tyrosine hydroxylase regulation,tyrosine kinase activation
ENSG00000137880,GCHFR,cellular stress response,genome maintenance,cellular proliferation,tumor suppressor function,dna repair mechanism,heme biosynthesis regulation
ENSG00000244687,UBE2V1,ubiquitin-conjugating enzyme,dna repair regulation,tumorigenic activation,transcription factor interaction,oncogenic potential,cellular protein degradation
ENSG00000175104,TRAF6,nf-κb signaling pathway,adaptor molecule function,cancer cell survival,metastasis promotion,tumor growth facilitation,emt regulation
ENSG00000134070,IRAK2,oncogenic signaling,immune evasion,tumor progression,therapeutic target,cell proliferation,immune checkpoint regulation
ENSG00000113070,HBEGF,angiogenesis,tumor progression,metastasis,cell migration,growth factor interaction,vascular endothelial growth factor regulation
ENSG00000198898,CAPZA2,cytoskeletal dynamics regulation,cell migration enhancement,tumor progression facilitation,metastasis promotion,oncogenic potential,overexpression in tumors
ENSG00000077549,CAPZB,cellular regulation,actin filament assembly,cell migration inhibition,prognostic marker,cancer cell survival,cytoskeletal dynamics
ENSG00000177938,CAPZA3,actin filament regulation,cell migration,cytoskeletal stability,cell invasion,metastatic potential,tumorigenesis marker
ENSG00000116489,CAPZA1,actin cytoskeleton regulation,cell migration and invasion,epithelial-to-mesenchymal transition,oncogenic potential,cell survival,genetic mutations
ENSG00000114745,GORASP1,aberrant protein expression,cell surface regulation,endosomal sorting complexes,tumorigenesis promotion,metastasis modulation,pi3k/akt pathway interaction
ENSG00000167110,GOLGA2,er dysregulation,protein misfolding,oncogenesis,cell proliferation,tumor progression,genomic instability
ENSG00000106799,TGFBR1,tgf-β signaling,epithelial-to-mesenchymal transition,metastatic potential,chemotherapy resistance,cell proliferation,apoptosis inhibition
ENSG00000088832,FKBP1A,tumor suppression,protein-protein interaction regulation,cell growth modulation,apoptosis regulation,steroid hormone receptor complex formation,epigenetic modification influence
ENSG00000113319,RASGRF2,**
mapk/erk pathway,guanine nucleotide-releasing factor activity,oncogenic driver,cell proliferation,epigenetic regulation,chromatin remodeling 
**
ENSG00000058335,RASGRF1,ras activation,oncogenic protein modification,cell cycle regulation,tumor progression,cancer driver gene,protein-protein interaction
ENSG00000120251,GRIA2,cell proliferation,tumor progression,glutamate receptor function,receptor activation,signal transduction,mutation hotspot
ENSG00000155511,GRIA1,glutamate receptor function,cell proliferation regulation,signal transduction modulation,tumor progression facilitation,protein interaction activation,apoptosis evasion promotion
ENSG00000105397,TYK2,aberrant jak/stat signaling,cancer immunomodulation,cell proliferation enhancement,immune evasion mechanisms,oncogenic pathway activation,tumor growth promotion
ENSG00000142166,IFNAR1,antitumor immune response,cancer immunotherapy target,immune evasion mechanisms,jak/stat signaling pathway activation,pi3k/akt pathway modulation,tumor progression
ENSG00000162851,TFB2M,dna repair deficiency,genomic instability,transcription regulation,cell cycle progression,apoptosis inhibition,chromatin modification
ENSG00000099821,POLRMT,mitochondrial rna polymerase activity,increased energy metabolism,enhanced cell proliferation,overexpression in cancer cells,regulation of mitochondrial biogenesis,interaction with dna-binding proteins
ENSG00000128191,DGCR8,microrna processing,genome instability,mirna biogenesis,oncogenic properties,genomic regulation,tumor suppressor
ENSG00000113360,DROSHA,mirna processing,rnase iii endonuclease activity,gene expression regulation,cancer development,tumor progression,therapeutic target
ENSG00000116918,TSNAX,adherens junction disruption,epithelial-to-mesenchymal transition (emt),metastasis promotion,cell cycle regulation,signaling pathway interaction,prognostic marker
ENSG00000211460,TSN,dna repair mechanism,genomic instability prevention,rna regulation,cell cycle control,gene expression modulation,cancer research relevance
ENSG00000076108,BAZ2A,chromatin remodeling,oncogenic driver,dna repair regulation,transcriptional activation,genomic instability,therapeutic resistance
ENSG00000119772,DNMT3A,dna methylation regulation,genome stability maintenance,tumor suppressor gene silencing,epigenetic disruption,loss of function mutation,therapeutic target
ENSG00000142182,DNMT3L,dna methylation,genomic instability,epigenetic regulation,tumor suppressor silencing,cancer prognosis,oncogenic mechanism
ENSG00000088305,DNMT3B,tumor suppressor gene silencing,genomic instability promotion,epigenetic regulation disruption,dna methylation enhancement,cell proliferation promotion,poor prognosis association
ENSG00000055130,CUL1,tumor suppressor function,ubiquitination regulation,dna repair pathway,cell cycle control,protein degradation,oncogenic mutations
ENSG00000111530,CAND1,genomic instability,tumor suppressor function,cullin-ring e3 ligase regulation,protein degradation inhibition,cell cycle regulation,dna repair maintenance
ENSG00000072274,TFRC,iron metabolism regulation,oncogene overexpression,cell proliferation enhancement,tumor progression facilitation,signaling pathway interaction,transmembrane receptor function
ENSG00000010704,HFE,iron metabolism disruption,oxidative stress induction,inflammation promotion,dna damage,tumorigenesis contribution,cellular response modulation
ENSG00000091513,TF,genomic instability,dna repair mechanism,transcriptional regulation,cell cycle progression,tumor progression,oncogenic process
ENSG00000225312,HSD17B8,cholesterol regulation,oxidative stress modulation,cell survival promotion,prognostic marker,inflammation pathway regulation,lipid metabolism dysregulation
ENSG00000145439,CBR4,actin cytoskeleton regulation,cell migration,tumor metastasis,oncogenic driver,signaling pathway interaction,protein overexpression
ENSG00000157456,CCNB2,cell cycle regulation,constitutive overexpression,genomic instability,oncogenesis driver,protein kinase activation,mitotic progression
ENSG00000100241,SBF1,transcriptional regulation,rna polymerase ii recruitment,chromatin remodeling,cell cycle regulation,gene expression dysregulation,tumor suppressor function
ENSG00000087053,MTMR2,mtm family phosphatase,pten regulation,pi3k/akt signaling enhancement,cell proliferation modulation,prognostic biomarker,dna damage response
ENSG00000003987,MTMR7,dephosphorylation activity,dna damage response,cell signaling regulation,tumor suppressor interaction,genome stability maintenance,oncogenic pathway modulation
ENSG00000104643,MTMR9,pi3p regulation,akt pathway modulation,phosphatase activity,cellular proliferation,tumor progression,genomic instability
ENSG00000051382,PIK3CB,pi3k/akt signaling pathway regulation,constitutive activation mutations,oncogenic driver,tumor progression promotion,cell survival enhancement,interaction with dna repair pathways
ENSG00000105647,PIK3R2,pi3k/akt pathway,constitutive activation,oncogenic driver,tumor progression,metastasis promotion,genomic instability
ENSG00000171608,PIK3CD,pi3k/akt signaling pathway,oncogenic process,cellular proliferation,therapeutic target,genomic profiling,signaling cascade
ENSG00000117461,PIK3R3,negative regulator,constitutive activation,pi3k/akt signaling,cell migration,metabolic regulation,tumor suppression
ENSG00000141506,PIK3R5,pi3k/akt signaling,tumor progression,cell proliferation,regulatory subunit interaction,oncogenic process activation,genomic alteration
ENSG00000105851,PIK3CG,gain of function mutations,constitutive activation,pi3k/akt pathway,oncogenic processes,tumor initiation,tumor progression
ENSG00000169499,PLEKHA2,pi3k/akt signaling pathway,phosphoinositide regulation,tumor progression influence,genomic instability impact,mutation hotspot significance,cancer cell migration modulation
ENSG00000163629,PTPN13,oncogenic kinase inhibition,tumor suppressor function,cell growth regulation,tyrosine phosphatase activity,signaling pathway modulation,tissue down-regulation
ENSG00000107679,PLEKHA1,cellular adhesion,constitutive activation,epithelial-to-mesenchymal transition,genomic instability,tumor suppressor function,cell cycle regulation
ENSG00000139505,MTMR6,aberrant expression,cell proliferation,cancer progression,tumor suppressor,oncogenic processes,phosphatidylinositol 3-kinase signaling
ENSG00000133812,SBF2,homologous recombination repair,genomic instability,oncogenic pathways,chromatin remodeling,brisc complex,ubiquitin-mediated proteolysis
ENSG00000171100,MTM1,cancer driver gene,tumor suppressor function loss,oncogenic signaling pathway,cell cycle regulation disruption,phosphatase activity modulation,genomic instability increase
ENSG00000150712,MTMR12,cellular regulation,pi3k/akt signaling,tumor suppressor function,dephosphorylation activity,cancer progression association,cellular homeostasis disruption
ENSG00000033327,GAB2,gab2 adapter protein function,oncogenic signaling,pi3k/akt pathway activation,cell proliferation enhancement,tumor migration facilitation,poor prognosis marker
ENSG00000150995,ITPR1,calcium signaling disruption,oncogenic process promotion,genomic instability driver,cellular stress response modulation,protein-protein interaction critical,signaling pathway regulation alteration
,MRVI1,microtubule regulation,cell migration,tumor progression,protein-protein interaction,cancer aggressiveness,microtubule stability
ENSG00000111679,PTPN6,loss of function mutations,aberrant signaling pathway activation,cell proliferation enhancement,tumor progression promotion,angiogenesis regulation,immune suppression modulation
ENSG00000261371,PECAM1,tumor progression,metastasis promotion,cell adhesion regulation,vascular endothelial growth factor expression,prognostic marker,breast cancer aggressiveness
ENSG00000179295,PTPN11,oncogenic activation,gain-of-function mutations,ras/mapk pathway,tumor suppressor,cell proliferation regulation,therapeutic target
ENSG00000160712,IL6R,tumor progression,immune evasion,metastasis facilitation,cell proliferation enhancement,angiogenesis promotion,inflammatory microenvironment creation
ENSG00000136244,IL6,jak/stat3 pathway,constitutive expression,epithelial-to-mesenchymal transition,tumor progression,therapeutic target,genomic profiling
ENSG00000115415,STAT1,transcription factor activation,immune response modulation,apoptosis induction,cell survival regulation,dna damage response,pro-inflammatory signaling pathway activation
ENSG00000168610,STAT3,oncogene,constitutive activation,cell proliferation,transcription factor activity,apoptosis resistance,metastasis promotion
ENSG00000128052,KDR,vegfr2 signaling,angiogenesis promotion,tumor progression,endothelial cell activation,inflammation induction,immune suppression
ENSG00000113905,HRG,heparan sulfate proteoglycans interaction,epithelial-to-mesenchymal transition,cell migration and invasion,angiogenesis promotion,tumor progression and metastasis,poor prognosis biomarker
ENSG00000122194,PLG,fibrinolysis regulation,tissue remodeling,extracellular matrix degradation,tumor growth promotion,metastasis facilitation,cancer cell invasion
ENSG00000182718,ANXA2,cell migration,tumor progression,cancer metastasis,protein interaction,apoptosis modulation,cytoskeleton regulation
ENSG00000197747,S100A10,tumor progression,cell migration and invasion,extracellular matrix degradation,apoptosis inhibition,protein interaction and regulation,gene expression modulation
ENSG00000276838,SERPINF2,angiogenesis promotion,cell migration regulation,hypoxia response regulation,immunosuppression induction,poor prognosis indicator,pro-angiogenic factor expression
ENSG00000122861,PLAU,tumor progression,metastasis promotion,extracellular matrix degradation,cell migration facilitation,therapeutic target,prognostic marker
ENSG00000011422,PLAUR,cell proliferation,metastasis,epithelial-to-mesenchymal transition (emt),angiogenesis,cell migration,tumor progression
ENSG00000165240,ATP7A,chemoresistance,copper transport regulation,tumor progression modulation,chemotherapy regimen interaction,x-linked disease association,cellular homeostasis maintenance
ENSG00000120509,PDZD11,overexpression,cell proliferation,tumor aggressiveness,protein-protein interactions,subcellular localization regulation,cancer prognosis
ENSG00000103249,CLCN7,chloride channel regulation,osteoclast activity modulation,cell proliferation enhancement,tumor aggressiveness promotion,immune response dysregulation,cancer immunosurveillance disruption
ENSG00000081087,OSTM1,lysosomal regulation,tumor progression,protein-protein interaction,cellular degradation,metastasis promotion,oncogenic process enhancement
ENSG00000136810,TXN,oxidative stress resistance,thioredoxin function,cell survival promotion,tumor tissue upregulation,protein interaction modulation,redox balance regulation
ENSG00000265972,TXNIP,cellular senescence,apoptosis inhibition,oxidative stress induction,cancer cell growth,dna damage enhancement,nf-κb pathway interaction
ENSG00000162711,NLRP3,nlrp3 inflammasome activation,inflammation regulation,immune evasion promotion,tumor microenvironment modulation,pro-inflammatory cytokine production,damp recognition
ENSG00000103313,MEFV,inflammasome regulation,pro-inflammatory cytokine release,autoinflammatory disease association,immune cell modulation,tumor microenvironment influence,cancer prognosis impact
ENSG00000140368,PSTPIP1,pi3k/akt pathway interaction,cancer cell proliferation,actin cytoskeleton regulation,potential therapeutic target,signaling pathway modulation,biomarker candidate
ENSG00000103490,PYCARD,apoptosis regulation,inflammasome formation,immune response modulation,programmed cell death activation,inflammation pathway interaction,tumor suppressor function
ENSG00000135346,CGA,tumor progression,metastasis promotion,cell proliferation enhancement,oncogene role,prognostic marker,immunoglobulin superfamily member
ENSG00000104826,LHB,hormone regulation,luteinizing hormone subunit,cell signaling disruption,aberrant expression patterns,reproductive dysregulation,tumor microenvironment modulation
ENSG00000126895,AVPR2,pi3k/akt pathway interactions,dysregulation,cell proliferation enhancement,tumor progression driver,therapeutic target potential,cell signaling alterations
ENSG00000101200,AVP,angiogenesis promotion,pro-oncogenic function,vasodilation regulation,cell proliferation,therapeutic target,signaling pathway activation
ENSG00000115263,GCG,protein processing,glucose metabolism,lipid metabolism,tumor growth promotion,cell proliferation stimulation,peptide hormone regulation
ENSG00000215644,GCGR,glucose metabolism regulation,cellular metabolic reprogramming,tumor growth promotion,therapeutic target identification,g protein-coupled receptor signaling,signaling pathway modulation
ENSG00000122679,RAMP3,g-protein coupled receptor regulation,tumor progression,cell proliferation enhancement,apoptosis inhibition,protein interaction modification,receptor activity modulation
ENSG00000004948,CALCR,calcitonin signaling pathway,metastatic potential,tumor progression,epithelial-to-mesenchymal transition,cell migration,g protein-coupled receptor activity
ENSG00000132329,RAMP1,gpcr regulation,oncogenic signaling,tumor progression,increased expression,cell growth promotion,metastasis facilitation
ENSG00000134200,TSHB,thyroid hormone regulation,cell proliferation modulation,tumor progression association,oncogenic pathway modulation,glycoprotein hormone function,pituitary gland expression
ENSG00000179600,GPHB5,glycosphingolipid metabolism,proliferation regulation,apoptosis regulation,cell signaling interaction,tumor progression,therapeutic target
ENSG00000149735,GPHA2,regulation of insulin signaling,interaction with akt substrate 1,role in pi3k/akt pathway,oncogenic potential,upregulation in breast cancer,glucose metabolism regulation
ENSG00000064989,CALCRL,metastasis promotion,cell migration regulation,tumor progression,biomarker potential,prognostic significance,pi3k/akt pathway activation
ENSG00000131477,RAMP2,g-protein coupled receptor regulation,cell proliferation,tumor metastasis,calcium signaling pathway,receptor activation,cell migration
ENSG00000065325,GLP2R,glucose metabolism,nutrient absorption,cellular growth regulation,oncogenic potential,metabolic regulation,tumorigenesis
ENSG00000131808,FSHB,fsh regulation,tumor aggressiveness,cell proliferation,apoptosis resistance,oncogenic processes,pi3k/akt pathway interaction
ENSG00000138448,ITGAV,oncogenic properties,tumor progression,cell adhesion and migration,enhanced proliferation,epithelial to mesenchymal transition,prognostic marker
ENSG00000082781,ITGB5,cell adhesion,cell migration,tumor progression,poor prognosis,apoptosis resistance,metastatic potential
ENSG00000103496,STX4,cellular proliferation,apoptosis evasion,vesicle fusion regulation,membrane trafficking modulation,signaling pathway alteration,tumor progression
ENSG00000265808,SEC22B,protein transport regulation,tumor progression promotion,dna repair pathway interaction,biomarker potential,cell signaling regulation,vesicular trafficking control
ENSG00000106571,GLI3,hedgehog signaling pathway,loss of function mutations,tumor growth promotion,cell proliferation enhancement,transcriptional regulation,oncogenic pathway activation
ENSG00000185920,PTCH1,hedgehog signaling,tumor suppressor function,gain of function mutations,tumor progression,cell proliferation,apoptosis suppression
ENSG00000111087,GLI1,hh signaling pathway,constitutive activation,oncogenic transcription factor,cell proliferation,tumor suppressor regulation,genomic instability
ENSG00000074047,GLI2,hedgehog signaling,transcriptional regulation,cell proliferation,oncogenic properties,tumor progression,metastasis
ENSG00000107882,SUFU,hedgehog signaling,gain of function mutations,tumor suppressor,dna damage,cell proliferation,genomic instability
ENSG00000133961,NUMB,notch pathway regulation,tumor suppressor function,apoptosis regulation,cell cycle control,protein interaction,signaling pathway alteration
ENSG00000078747,ITCH,nf-κb regulation,gain of function mutations,cell signaling pathway,apoptosis regulation,tumor progression,therapeutic target
ENSG00000011198,ABHD5,lipid metabolism regulation,pro-tumorigenic metabolite regulation,tumor suppressor function,metabolic pathway disruption,cell migration and invasion,therapeutic target potential
ENSG00000166819,PLIN1,lipid metabolism,overexpression,cell proliferation,survival,apoptosis resistance,aggressive tumor behavior
ENSG00000079435,LIPE,lipid metabolism regulation,tumor microenvironment modulation,hormone-sensitive lipolysis,cell membrane fluidity alteration,proliferation and survival enhancement,estrogen signaling pathway interaction
ENSG00000170323,FABP4,lipid metabolism regulation,fatty acid storage promotion,cell proliferation enhancement,metastasis facilitation,oncogenic signaling interaction,epithelial-to-mesenchymal transition regulation
ENSG00000153822,KCNJ16,regulatory interaction with pi3k/akt,tumor growth promotion,cell cycle regulation,potassium channel modulation,homologous recombination involvement,oncogenic overexpression
ENSG00000157551,KCNJ15,channel dysfunction,cell cycle disruption,oncogenic driver mutations,metastatic potential,therapeutic target,ion channel regulation
ENSG00000177807,KCNJ10,potassium channel function,tumor progression,dna repair regulation,cell proliferation modulation,signaling pathway interaction,cancer cell survival enhancement
ENSG00000161921,CXCL16,angiogenesis,biomarker candidate,chemokine signaling,cytokine production,immunosuppression,metastasis facilitation
ENSG00000172215,CXCR6,cxcl16 axis,promotes angiogenesis,overexpressed in tumors,tumor progression,therapeutic target,immunosuppressive cells
ENSG00000197405,C5AR1,complement system regulation,immune evasion,mapk/erk pathway activation,metastasis promotion,proliferation enhancement,tumor progression support
ENSG00000106804,C5,tumor progression,angiogenesis,metastasis,tumor growth,cell proliferation,immune evasion
ENSG00000006210,CX3CL1,immune suppression,chemokine signaling,tumor progression,cell migration,immune evasion,t-regulatory cell recruitment
ENSG00000168329,CX3CR1,**
chemotaxis,tumor progression,immune evasion,metastasis,g protein-coupled receptor signaling,chemokine interaction 
**
ENSG00000179002,TAS1R2,genomic instability,aberrant expression,aggressive tumor behavior,cell proliferation,cell survival signaling,therapeutic target
ENSG00000169962,TAS1R3,tumor progression,overexpression,cell proliferation,protein interaction,therapeutic target,genomic amplification
ENSG00000173662,TAS1R1,epithelial-to-mesenchymal transition,upregulated expression,poor prognosis marker,cell migration regulation,invasive properties modulation,tumor progression facilitation
ENSG00000136928,GABBR2,gaba b receptor activity,cell proliferation,therapeutic target,signaling pathway modulation,neurotransmission regulation,metabotropic receptor function
ENSG00000204681,GABBR1,gaba_b receptor regulation,synaptic transmission modulation,tumor cell proliferation inhibition,oncogenic process promotion,cell growth enhancement,angiogenesis facilitation
ENSG00000243646,IL10RB,anti-inflammatory cytokine response,cell survival,dysregulation of immune response,immunosuppressive microenvironment,increased tumorigenesis,stat3 activation
ENSG00000104064,GABPB1,transcriptional regulation,oncogenic processes,tumor progression,metastasis,signal transduction pathway modulation,therapeutic target
ENSG00000154727,GABPA,cell cycle regulation,transcriptional regulation,oncogene activation,apoptosis suppression,chromatin remodeling,promoter hypermethylation
ENSG00000083312,TNPO1,nuclear import function,brca1 interaction,chromatin remodeling,cell cycle regulation,dna repair modulation,genomic stability maintenance
ENSG00000117245,KIF17,cell division regulation,genomic stability maintenance,microtubule dynamics regulation,therapeutic target,oncogenic pathway interaction,epithelial-to-mesenchymal transition (emt)
ENSG00000243955,GSTA1,cellular detoxification,genomic stability maintenance,oxidative stress reduction,prognostic marker,therapeutic target,dna repair regulation
ENSG00000244067,GSTA2,antioxidant activity,detoxification mechanism,oxidative stress regulation,cellular defense mechanisms,chemotherapy resistance,tumor microenvironment
ENSG00000001084,GCLC,glutathione synthesis,nrf2 transcription factor regulation,redox balance modulation,antioxidant response activation,genotoxic stress mitigation,therapeutic target for sensitization
ENSG00000023909,GCLM,glutathione synthesis,oxidative stress,cell survival pathways,redox balance regulation,dna damage repair,protein interaction
ENSG00000254647,INS,insulin signaling pathway,receptor tyrosine kinase activity,enhanced cell proliferation,metabolic regulation,tumor progression,therapeutic resistance
ENSG00000171105,INSR,insulin signaling pathway,gain of function mutations,tumor progression,metabolic regulation,cell proliferation,none
ENSG00000173208,ABCD2,dna repair modulation,chemosensitivity alterations,tumor resistance development,efflux pump regulation,cellular response modification,protein-protein interactions
ENSG00000101986,ABCD1,mitochondrial transport,nuclear-mitochondrial interactions,redox regulation,cell survival enhancement,mitochondrial dysfunction,therapeutic target
ENSG00000117528,ABCD3,lipid transport,peroxisomal import,fatty acid metabolism,cholesterol regulation,oncogenic role,tumor progression marker
ENSG00000138075,ABCG5,half-transporter function,bile efflux regulation,cholesterol transport disruption,lipid disorder association,cellular survival regulation,apoptosis modulation
ENSG00000143921,ABCG8,sterol efflux,cholesterol homeostasis,lipid transport regulation,tumor growth promotion,genetic mutations association,cellular lipid metabolism alteration
ENSG00000160716,CHRNB2,cell signaling pathway,ligand-gated ion channel function,neurotransmitter release regulation,proliferation promotion,tumor growth facilitation,chemoresistance enhancement
ENSG00000101204,CHRNA4,neuronal nicotinic receptors,pentameric ion channels,calcium influx regulation,cell proliferation modulation,survival pathway interaction,muscle control and contraction
ENSG00000080644,CHRNA3,neurotransmitter regulation,cancer progression,cell migration,metastasis promotion,pi3k/akt pathway interaction,poor prognosis biomarker
ENSG00000117971,CHRNB4,neuronal signaling pathway,apoptosis regulation,cell survival enhancement,dna repair mechanism modulation,cell growth promotion,signaling pathway interaction
ENSG00000111206,FOXM1,cell proliferation,genomic instability,transcription factor activation,oncogenic transformation,tumor suppressor interaction,g2/m phase regulation
ENSG00000166851,PLK1,cell cycle regulation,genomic instability,oncogenesis,apoptosis inhibition,cancer stem cell maintenance,brca1 interaction
ENSG00000117724,CENPF,chromosomal instability,centromere dysfunction,oncogene overexpression,chromosome segregation,mitotic checkpoint regulation,protein kinase activation
ENSG00000115353,TACR1,**
neurokinin 1 receptor signaling,constitutive activation,aberrant expression,cell proliferation,tumor progression,regulatory element interaction 
**
ENSG00000006128,TAC1,tumor growth promotion,angiogenesis facilitation,cell proliferation enhancement,metastasis induction,immune evasion mechanism,inflammation modulation
ENSG00000075073,TACR2,neuropeptide receptor signaling,g-protein coupled receptor pathway,promotes cell survival,tumorigenesis driver,increased expression levels,modulates cellular responses
ENSG00000180914,OXTR,erk pathway activation,cell proliferation promotion,tumor progression facilitation,social behavior regulation disruption,stress response modulation alteration,g protein-coupled receptor function
ENSG00000101405,OXT,neurotransmitter regulation,pi3k/akt pathway modulation,cell survival enhancement,tumor progression facilitation,stress response regulation,reproductive function influence
ENSG00000147571,CRH,hpa axis regulation,cell proliferation,signaling pathway activation,tumor progression,therapeutic target,gene expression dysregulation
ENSG00000145708,CRHBP,tumor suppressor function,dysregulated expression,cellular regulation imbalance,immune response modulation,apoptosis promotion,crh interaction
ENSG00000123146,ADGRE5,tumor progression,cancer metastasis,cell migration regulation,oncogene activation,cell adhesion modulation,signaling pathway interaction
ENSG00000196352,CD55,complement regulation,immune evasion,tumor progression,cell surface modulation,glycoprotein function,oncogenic potential
ENSG00000100211,CBY1,dna damage response,genome stability maintenance,tumor suppressor function,brca pathway regulation,homologous recombination repair,nuclear protein interaction
ENSG00000168036,CTNNB1,wnt signaling pathway,cell proliferation regulation,transcriptional activation,oncogenesis driver,therapeutic target,genomic instability
ENSG00000178585,CTNNBIP1,tumor suppressor function loss,wnt/β-catenin pathway activation,hippo signaling dysregulation,oncogene overexpression,cell proliferation enhancement,chemoresistance promotion
ENSG00000100888,CHD8,chromatin remodeling,oncogenic transcription factor,constitutive activation mutations,cell proliferation regulator,metastasis promoter,epigenetic regulator interaction
ENSG00000180398,MCFD2,genomic instability,proliferation regulation,cell survival pathway,iron-sulfur cluster assembly,dna repair facilitation,energy metabolism regulation
ENSG00000074695,LMAN1,erad dysfunction,oncogenic substrate degradation,cellular homeostasis regulation,protein folding modulation,therapeutic target potential,tumor progression facilitation
ENSG00000170348,TMED10,tumor suppressor function,vesicle transport regulation,cellular response modulation,protein processing regulation,mapk/erk signaling pathway interaction,decreased expression associated with tumor progression
ENSG00000086598,TMED2,oncogenesis,cell proliferation regulation,protein transport regulation,endoplasmic reticulum-golgi apparatus interaction,tumor aggressiveness association,cancer prognosis correlation
ENSG00000010610,CD4,tumor-immune interaction,immune activation,cancer cell heterogeneity,t cell differentiation,antigen presentation,immunotherapy target
ENSG00000182866,LCK,t-cell receptor signaling,tyrosine phosphorylation,cell proliferation,apoptosis resistance,metastasis promotion,non-receptor kinase activity
ENSG00000115839,RAB3GAP1,amplification,cell proliferation,tumor progression,epithelial-to-mesenchymal transition,promoter region alteration,cancer driver gene
ENSG00000118873,RAB3GAP2,regulation of cell growth,gtpase-activating protein (gap) activity,microtubule dynamics regulation,oncogenic pathway activation,cell proliferation promotion,tumorigenesis contribution
ENSG00000148053,NTRK2,receptor tyrosine kinase,constitutive activation,oncogenic driver,tumor progression,therapeutic target,signaling pathway dysregulation
ENSG00000176697,BDNF,angiogenesis promotion,cell migration and invasion,oncogenic signaling pathway modulation,poor prognosis marker,tumor progression facilitation,therapeutic target potential
ENSG00000225950,NTF4,pi3k/akt pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,gene amplification
ENSG00000100385,IL2RB,il-2rβ overexpression,tumor microenvironment modulation,immune evasion mechanisms,cancer stem cell maintenance,cell proliferation enhancement,genetic amplification
ENSG00000162434,JAK1,jak/stat pathway activation,constitutive phosphorylation,gain of function mutations,tumor progression,therapeutic target,gene amplification
ENSG00000105639,JAK3,jak/stat signaling,constitutive activation,tumor progression,oncogenic mutations,cell proliferation,therapeutic resistance
ENSG00000147168,IL2RG,immune regulation,constitutive activation,cell proliferation,tumor progression,immunotherapeutic target,genetic disorder
ENSG00000120899,PTK2B,cell migration,tumor progression,cytoskeletal reorganization,metastasis,signaling pathway modulation,focal adhesion formation
ENSG00000105246,EBI3,angiogenesis promotion,immune evasion,tumor cell migration,poor prognosis marker,cancer metastasis,cell differentiation regulation
ENSG00000197272,IL27,apoptosis induction,cytokine regulation,immune suppression,stat1 activation,tumor growth inhibition,apoptosis promotion
ENSG00000110400,NECTIN1,cell adhesion,promotes metastasis,overexpressed in cancer,immune system modulation,tumor progression,cell migration
ENSG00000177707,NECTIN3,cell-cell interaction,dysregulated expression,tumor progression,metastasis facilitation,protein-protein interactions,cancer metastasis
ENSG00000143217,NECTIN4,adhesion molecule function,cell signaling regulation,immune response modulation,metastasis promotion,poor prognosis biomarker,signaling pathway interaction
ENSG00000130202,NECTIN2,cell adhesion molecule,tumor progression,oncogene,cell recognition,immunoglobulin superfamily,pi3k/akt pathway interaction
ENSG00000073008,PVR,overexpression,tumor progression,cell adhesion,epithelial-to-mesenchymal transition (emt),protein-protein interaction,metastasis promoter
ENSG00000113302,IL12B,cytokine signaling,immunomodulation,nf-kappab pathway activation,tumor immune evasion,immune checkpoint regulation,pro-inflammatory cytokines
ENSG00000168811,IL12A,immunomodulatory effects,cellular immunity activation,anti-tumor activity enhancement,immune regulation disruption,t cell activation promotion,cancer immunotherapy target
ENSG00000096996,IL12RB1,tumor evasion,immune suppression,signal transduction,immune activation,cell proliferation,regulatory mechanism
ENSG00000081985,IL12RB2,tumor suppression,disruption of immune surveillance,il-12/stat4 signaling pathway,constitutive activation of stat4,oncogenic process,genomic alterations
ENSG00000096968,JAK2,jak/stat pathway,constitutive activation,gain-of-function mutations,oncogenic transformation,tumor progression,genomic instability
ENSG00000137462,TLR2,tlr2 signaling,chronic inflammation,tumor microenvironment modulation,immune evasion,pattern recognition receptors,pro-inflammatory cytokine production
ENSG00000174125,TLR1,immune modulation,tumor microenvironment regulation,inflammation modulation,cancer cell behavior influence,prognostic marker,pathogen recognition
ENSG00000174130,TLR6,tumor microenvironment modulation,immune cell recruitment,pro-tumorigenic effects,signaling pathway activation,immunotherapy influence,receptor overexpression
ENSG00000168214,RBPJ,notch signaling pathway,gain of function mutations,aberrant activation,therapeutic target,cellular proliferation,chromatin remodeling
ENSG00000100603,SNW1,transcriptional co-activation,cell proliferation regulation,chromatin remodeling complex interaction,breast cancer progression,therapeutic target potential,transcription factor regulation
ENSG00000148400,NOTCH1,notch signaling pathway,oncogenic activation,gain of function mutations,tumor progression,metastasis,therapeutic target
ENSG00000100644,HIF1A,hypoxia-inducible transcription factor,constitutive activation,angiogenesis promoter,tumor metabolism enhancer,cell survival pathway activator,transcriptional regulator
ENSG00000101384,JAG1,notch signaling pathway,oncogene activation,gain of function mutations,tumor progression,cell proliferation regulation,apoptosis suppression
ENSG00000184916,JAG2,notch signaling pathway,cell differentiation,oncogenic roles,metastasis promotion,transcriptional regulation,cell proliferation
ENSG00000110395,CBL,cell cycle regulation,tumor suppressor function,ubiquitination pathway,receptor tyrosine kinase regulation,apoptosis modulation,genomic stability maintenance
ENSG00000149294,NCAM1,cellular migration,metastasis promotion,epithelial-to-mesenchymal transition,immune modulation,tumor evasion strategies,glycoprotein expression
ENSG00000130287,NCAN,wnt/β-catenin pathway modulation,tumor progression driver,cell adhesion regulation,apoptosis inhibition,epigenetic dysregulation,protein-protein interaction
ENSG00000134871,COL4A2,epithelial-to-mesenchymal transition,cell adhesion regulation,tumor progression association,metastasis correlation,poor prognosis marker,basement membrane component
ENSG00000187498,COL4A1,type iv collagen,basement membrane disruption,angiogenesis facilitation,metastasis promotion,extracellular matrix alteration,chemoresistance development
ENSG00000206435,HLA-C,immune evasion,tumor antigen presentation,cancer immunity,prognostic marker,mhc class i protein,genetic polymorphism
ENSG00000273686,B2M,tumor suppressor function,immune evasion mechanism,cell surface protein,antigen presentation pathway,cancer progression facilitation,gene overexpression
ENSG00000274739,KIR2DS5,ion channel function,cell membrane regulation,apoptosis modulation,cell proliferation regulation,tumor progression contribution,cell survival pathway influence
ENSG00000011600,TYROBP,immune cell activation,cell adhesion molecules,inflammation regulation,immunosurveillance dysregulation,tumor progression,signal transduction modulation
ENSG00000258227,CLEC5A,immune evasion,pro-tumorigenic inflammation,tumor microenvironment remodeling,angiogenesis promotion,epithelial-to-mesenchymal transition,cancer metastasis
ENSG00000096264,NCR2,immune modulation,inflammation regulation,tumor metastasis promotion,cancer progression,protein expression,genetic alteration
ENSG00000101307,SIRPB1,tumor progression,immune evasion,phagocytosis regulation,cell migration and invasion,epithelial-to-mesenchymal transition (emt),prognostic marker
ENSG00000124731,TREM1,immune modulation,inflammation regulation,tumor microenvironment,cell proliferation,angiogenesis promotion,immunosuppression enhancement
ENSG00000095970,TREM2,tumor progression,immune modulation,pro-tumorigenic microenvironment,cell survival enhancement,oncogenesis promotion,pik3ca interaction
ENSG00000186407,CD300E,immune modulation,tumor suppression,myeloid cell regulation,overexpression in cancer,favorable prognosis,immune checkpoint interaction
ENSG00000178789,CD300LB,immune regulation,tumor suppression,cell proliferation inhibition,adaptive immune response modulation,immunosuppressive pathway inhibition,therapeutic target
ENSG00000100351,GRAP2,pi3k/akt pathway regulation,growth factor signaling modulation,cellular survival enhancement,protein kinase activation,adaptor protein interaction,metabolic regulation
ENSG00000043462,LCP2,**
pi3k/akt signaling,constitutive activation,protein kinase regulation,t-cell receptor signaling,cell survival,oncogenic transformation
**
ENSG00000136158,SPRY2,regulation of cell growth signaling pathways,tumor suppressor function,fgfr/pdgfr pathway inhibition,negative feedback mechanism,cell proliferation regulation,genetic alterations in cancer
ENSG00000153071,DAB2,tumor suppressor,cell adhesion regulation,pi3k/akt pathway inhibition,epithelial-to-mesenchymal transition (emt) regulation,prognostic biomarker potential,apoptosis induction
ENSG00000081479,LRP2,lrp2-mediated endocytosis,tumor progression,cell adhesion modulation,apolipoprotein transport regulation,cholesterol metabolism dysregulation,overexpression correlation
ENSG00000124333,VAMP7,extracellular matrix interaction,tumor progression,cell invasion,metastasis promotion,vesicle-mediated transport,signaling pathway regulation
ENSG00000173744,AGFG1,dna repair pathway,genetic instability,tumor progression,proliferation regulation,cancer susceptibility,therapeutic target
ENSG00000078053,AMPH,endocytic pathway regulation,egfr internalization,phosphorylation-dependent regulation,tumor progression,prognostic marker,therapeutic target
ENSG00000136717,BIN1,tumor progression,metastasis facilitation,apoptosis dysregulation,genomic instability,cell differentiation regulation,autophagy regulation
ENSG00000161011,SQSTM1,autophagic processes,tumor progression,cellular stress responses,apoptosis regulation,protein degradation pathway,oncogenic signaling interactions
ENSG00000198909,MAP3K3,mapk signaling pathway,oncogenic activation,tumor growth promotion,cellular proliferation regulation,apoptosis resistance,protein-protein interaction
ENSG00000187840,EIF4EBP1,mtor signaling pathway,constitutive activation,gain of function mutations,tumor progression,therapeutic target,regulatory mechanism
ENSG00000151247,EIF4E,mrna translation regulation,cell proliferation promotion,oncogenic mrna translation,tumor progression facilitation,poor prognosis indicator,therapeutic target
ENSG00000134250,NOTCH2,notch signaling pathway,constitutive activation,transmembrane receptor function,oncogenic overexpression,cell differentiation regulation,apoptosis suppression
ENSG00000137496,IL18BP,il-18 regulation,pro-inflammatory signaling,tumor progression,immune evasion,oncogene expression,gene amplification
ENSG00000150782,IL18,inflammatory response,tumor progression,angiogenesis,immune suppression,pro-inflammatory microenvironment,cancer cell survival
ENSG00000115604,IL18R1,il-18 signaling pathway,tumor growth promotion,immune evasion,apoptosis suppression,cell proliferation enhancement,angiogenesis facilitation
ENSG00000164136,IL15,cell proliferation,oncogene activation,immune evasion mechanisms,angiogenesis promotion,tumor progression marker,immune regulatory function
ENSG00000134470,IL15RA,oncogenic signaling,tumor growth promotion,immune evasion,apoptosis resistance,angiogenesis promotion,malignant progression
ENSG00000126456,IRF3,apoptosis induction,cell survival regulation,immune response modulation,innate immunity activation,tumor suppression,cancer cell interaction
ENSG00000185507,IRF7,type i interferons activation,immune regulation,cytokine production,tumor microenvironment modulation,inflammation response,transcriptional regulation
ENSG00000005339,CREBBP,**

1. chromatin remodeling,2. transcriptional coactivator function disruption,3. oncogene activation,4. tumor suppressor gene suppression,5. cell proliferation enhancement,6. apoptosis resistance
ENSG00000074181,NOTCH3,notch signaling pathway,gain of function mutations,tumor progression,therapeutic target,cell cycle regulation,apoptosis suppression
ENSG00000163435,ELF3,oncogenic transcription factor,epithelial-to-mesenchymal transition (emt),wnt/β-catenin pathway interaction,cell migration regulation,tumor progression,biomarker potential
ENSG00000018236,CNTN1,oncogenic protein-protein interactions,cell migration regulation,tumor progression marker,adhesion molecule overexpression,signal transduction pathway involvement,epithelial-to-mesenchymal transition (emt) activation
ENSG00000110492,MDK,p53 regulation,tumor suppressor function loss,cell cycle progression,proteasomal degradation,apoptosis inhibition,genomic instability
ENSG00000198719,DLL1,notch signaling,cell fate determination,oncogenic transformation,therapeutic target,protein-protein interactions,genetic alterations
ENSG00000065978,YBX1,brca1 regulation,cell cycle progression,chromosomal instability,genomic instability,multifunctional protein,oncogenesis
ENSG00000164683,HEY1,oncogene activation,epithelial-to-mesenchymal transition (emt),angiogenesis,transcription factor activity,genomic instability,cell proliferation regulation
ENSG00000160973,FOXH1,transcriptional regulator,cellular differentiation,apoptosis induction,dna repair mechanisms,tumor suppressor role,cell cycle regulation
ENSG00000175550,DRAP1,brca1 interaction,chromatin regulation,dna repair mechanism,genomic stability maintenance,tumor suppressor function,apoptosis regulation
ENSG00000064309,CDON,cell signaling,tumor progression,metastasis,pi3k/akt pathway activation,cell growth regulation,therapeutic target
ENSG00000144857,BOC,cellular proliferation regulation,emt modulation,tumor progression enhancement,apoptosis suppression,transcriptional regulator function,overexpression correlation
ENSG00000110944,IL23A,il-23/il-17 axis,immunosuppressive activity,tumor-promoting effects,epithelial-to-mesenchymal transition,dna damage response regulation,cellular immune modulation
ENSG00000162594,IL23R,immunomodulation,pro-inflammatory cytokine production,tumor microenvironment modulation,immune cell recruitment,cancer risk increase,therapeutic target
ENSG00000138378,STAT4,immunomodulation,constitutive activation,enhanced cell proliferation,oncogenic function,biomarker potential,immunosuppressive tumor microenvironment
ENSG00000113889,KNG1,angiogenic promotion,kinin-kallikrein system activation,vasodilation enhancement,tumor progression facilitation,metastasis association,poor prognosis indicator
ENSG00000108561,C1QBP,apoptosis regulation,cellular interaction,tumor progression,therapeutic target,cancer cell survival,metastasis promotion
ENSG00000185010,F8,tumor progression,immunomodulation,vascularization,biomarker,therapeutic target,coagulation regulation
ENSG00000110799,VWF,angiogenesis promotion,thrombosis risk factor,cell adhesion facilitation,platelet aggregation promotion,glycoprotein function,hemostasis regulation
ENSG00000101981,F9,coagulation cascade,pro-coagulant environment,vitamin k-dependent,serine protease activity,hemostasis regulation,post-translational modification
ENSG00000143278,F13B,coagulation factor regulation,tumor progression,cell migration,metastasis facilitation,poor prognosis indicator,gene expression modulation
ENSG00000124491,F13A1,angiogenesis,vascular remodeling,tumor progression,metastasis,poor prognosis,cell growth signaling
ENSG00000115718,PROC,protein processing,tumor progression,metastasis,invasion,pro-tumor protein degradation,microenvironment remodeling
ENSG00000101000,PROCR,tumor suppressor,angiogenesis inhibition,metastasis regulation,coagulation pathway modulation,therapeutic target,genomic instability
ENSG00000154589,LY96,tumor suppressor function,epithelial-to-mesenchymal transition regulation,cell adhesion and migration regulation,protein-protein interactions,metastasis suppression,cooperative tumor suppressor activity
ENSG00000136869,TLR4,inflammation,cell proliferation,angiogenesis,pro-inflammatory cytokines,tumor microenvironment,oncogene signaling
ENSG00000163220,S100A9,calcium-binding protein,pro-tumorigenic microenvironment,tumor progression,metastasis driver,inflammation regulator,cell survival pathway
ENSG00000143546,S100A8,pro-tumorigenic,overexpression,microenvironment modulation,inflammation promotion,emt regulation,tumor cell proliferation
ENSG00000130522,JUND,transcription factor activity,oncogene activation,constitutive activation,cell cycle regulation,metastasis promotion,gene expression modulation
ENSG00000125740,FOSB,cell proliferation,transcriptional regulation,tumor progression,metastasis promotion,oncogenic potential,epithelial-to-mesenchymal transition
ENSG00000242335,CFB,tumor progression,metastasis regulation,immunomodulation,protein-protein interaction,tissue damage regulation,antigen presentation
ENSG00000125730,C3,tumor microenvironment modulation,angiogenesis facilitation,immune evasion mechanism,inflammation regulation,cell adhesion modification,cancer progression enhancement
ENSG00000104879,CKM,metabolic regulation,energy metabolism,cell migration,angiogenesis,prognostic biomarker,tumor progression
ENSG00000166165,CKB,redox regulation,tumor metabolism,chemotherapy resistance,oxidative stress modulation,enzyme dysregulation,drug metabolism
ENSG00000117592,PRDX6,antioxidant function,anti-apoptotic properties,oxidative stress regulation,cellular redox balance,peroxiredoxin enzyme activity,cancer progression enhancement
ENSG00000084207,GSTP1,oncogene,cellular detoxification,signaling pathway modulation,redox balance regulation,tumor progression facilitation,cancer stem cell maintenance
ENSG00000185122,HSF1,stress response,heat shock protein activation,tumor progression,cell survival enhancement,dna damage tolerance,oxidative stress adaptation
ENSG00000230989,HSBP1,cellular proliferation,chromatin remodeling,gene regulation,histone modification,oncogenic processes,tumor progression
ENSG00000108953,YWHAE,oncogenic activation,signaling pathway regulation,cell cycle progression,tumor progression,prognostic marker,epithelial-to-mesenchymal transition
ENSG00000158941,CCAR2,genomic instability,cell cycle progression,adaptor molecule function,dna repair regulation,tumor aggressiveness,apoptosis resistance
ENSG00000096717,SIRT1,deacetylase activity,genome stability regulation,cellular senescence modulation,apoptosis suppression,tumor progression promotion,dna repair enhancement
ENSG00000125968,ID1,tumor progression,oncogene function,epithelial-to-mesenchymal transition,angiogenesis regulation,cell cycle regulation,genome instability
ENSG00000157557,ETS2,oncogenesis regulation,transcriptional activation,cell proliferation regulation,angiogenesis promotion,metastasis facilitation,stat3-nf-κb interaction
ENSG00000105722,ERF,dna repair mechanism,genomic stability,platinum-based chemosensitivity,tumor suppressor function,cell cycle regulation,protein-protein interactions
ENSG00000197442,MAP3K5,cellular proliferation,tumor progression,dysregulation of mlk7 activity,genomic instability,protein kinase activation,therapeutic target
ENSG00000147883,CDKN2B,cell cycle regulation,tumor suppressor activity,genomic stability,oncogenic transformation,cell proliferation inhibition,chromosome 9p21 deletion/methylation
ENSG00000172216,CEBPB,transcriptional regulation,oncogenic processes,cell proliferation,apoptosis resistance,dna repair,genomic instability
ENSG00000198178,CLEC4C,immune suppression,tumor evasion,cell surface recognition,cancer immunology,metastasis promotion,poor prognosis marker
ENSG00000158869,FCER1G,mast cell activation,tumor progression,cellular proliferation,signaling pathway regulation,genomic instability,epigenetic modification
ENSG00000166523,CLEC4E,immunosurveillance evasion,tumor progression,metastasis promotion,cell adhesion modulation,therapeutic target,pi3k/akt pathway interaction
ENSG00000006062,MAP3K14,nf-κb signaling,constitutive activation,non-canonical pathway,gain of function mutations,tumor progression,therapeutic target
ENSG00000213341,CHUK,**
nf-κb signaling pathway,constitutive activation,gain of function mutations,dna damage response disruption,cell cycle progression enhancement,tumor suppressor regulation
ENSG00000077150,NFKB2,nf-κb pathway activation,cell survival regulation,tumor progression enhancement,genetic transcriptional regulation,oncogene interaction,pro-tumorigenic gene expression
ENSG00000104856,RELB,nf-κb pathway,constitutive activation,tumor progression,cell proliferation inhibition,apoptosis evasion,transcriptional regulation
ENSG00000172175,MALT1,**

nf-?b signaling,cell survival,tumor progression,apoptosis resistance,metastasis facilitation,immune evasion 
**
ENSG00000064012,CASP8,apoptosis regulation,cellular homeostasis,extrinsic pathway activation,gene mutations,protein dysfunction,tumor progression
ENSG00000090659,CD209,dendritic cell interaction,glycosylation regulation,immune modulation,cell adhesion,tumor microenvironment,cancer immunology
ENSG00000108622,ICAM2,cell adhesion modulation,immune response regulation,tumor progression facilitation,metastasis promotion,angiogenesis influence,cell migration enhancement
ENSG00000075218,GTSE1,apoptosis regulation,mitotic checkpoint control,cell cycle progression,tumor progression resistance,chemotherapy resistance,protein-protein interaction
ENSG00000117399,CDC20,apc-mediated degradation pathway,chromosome separation,genomic instability,oncogenic process,tumorigenesis,ubiquitination mechanism
ENSG00000164109,MAD2L1,genomic instability,chromosome segregation,spindle assembly checkpoint,tumor progression,therapeutic resistance,aneuploidy
ENSG00000136997,MYC,oncogene activation,transcriptional regulation,cell proliferation enhancement,apoptosis resistance,cell cycle dysregulation,prognostic marker
ENSG00000123374,CDK2,cell proliferation,cell cycle regulation,cancer driver mutation,oncogenic pathway,therapeutic target,genomic instability
ENSG00000105173,CCNE1,overexpression,cell cycle disruption,oncogene activation,tumor growth promotion,chemotherapy resistance,cancer stem cell maintenance
ENSG00000112312,GMNN,aberrant expression,cell cycle regulation,g2/m phase transition,oncogenic processes,tumor progression,cell proliferation
ENSG00000167513,CDT1,chromatin regulation,cell cycle progression,dna replication initiation,genomic instability,oncogenic function,histone modification
ENSG00000006634,DBF4,dna replication,genomic instability,chromatin loading,cell cycle progression,mcm helicase interaction,replication origin activation
ENSG00000097046,CDC7,dna replication initiation,s phase regulation,g2/m checkpoint activation,cell cycle progression,tumor metastasis,therapeutic target
ENSG00000133101,CCNA1,cell cycle regulation,cyclin-dependent kinase activation,genomic instability,dna replication,oncogenic process,tumor growth
ENSG00000145386,CCNA2,homologous recombination repair defects,tumor growth inhibition,cyclin-dependent kinase 2 activation,cell cycle dysregulation,dna replication,genomic instability
ENSG00000139289,PHLDA1,cell cycle regulation,apoptosis resistance,transcriptional regulation,tumor suppressor function,cancer progression,metastasis suppression
ENSG00000288307,CTDNEP1,cell cycle regulation,dna repair,protein-protein interaction,oncogenic driver,tumor suppressor activity,cell proliferation enhancement
ENSG00000205423,CNEP1R1,endosomal sorting,autophagy regulation,tumor progression,cell proliferation,protein modulation,gene expression alteration
ENSG00000135476,ESPL1,chromosomal segregation,genomic instability,aneuploidy promotion,cell proliferation,survival factor,oncogenic process
ENSG00000164611,PTTG1,mitotic checkpoint,cell cycle regulation,tumor suppressor,genomic instability,oncogenic function,apoptosis suppression
ENSG00000129933,MAU2,genome stability,dna damage response,homologous recombination repair,non-homologous end joining,tumor progression,genomic instability
ENSG00000164190,NIPBL,genomic instability,chromatin regulation,cohesin loading,dna replication,genome maintenance,protein-protein interactions
ENSG00000112029,FBXO5,genomic integrity,cell cycle regulation,dna repair mechanisms,oncogenic pathway activation,tumor suppressor function,proteasomal degradation
ENSG00000073712,FERMT2,rho gtpase regulation,actin cytoskeleton remodeling,cell migration promotion,metastasis facilitation,tumor aggressiveness enhancement,genomic instability association
ENSG00000162458,FBLIM1,regulation of epithelial-to-mesenchymal transition,tumor suppressor function,loss of adhesion protein interactions,regulation of p53 pathway,dna repair mechanisms,metastatic potential enhancement
ENSG00000150093,ITGB1,tumor progression,metastasis,cell adhesion,angiogenesis,tumor microenvironment,oncogene expression
ENSG00000166333,ILK,cell adhesion disruption,pi3k/akt pathway interaction,tumor progression facilitation,metastasis promotion,chemoresistance induction,cell migration regulation
ENSG00000197702,PARVA,chromatin regulation,genomic stability,gene expression modulation,histone interaction,oncogenesis promotion,tumor progression
ENSG00000129675,ARHGEF6,cell migration,rho gtpase activation,oncogenic potential,cell invasion,signaling pathway modulation,tumor progression
ENSG00000188677,PARVB,chromatin remodeling,epigenetic regulation,nurd complex member,oncogenic transcription,cell proliferation,tumor suppressor
ENSG00000148484,RSU1,cell proliferation,genomic instability,tumor progression,dna replication,oncogenic function,protein overexpression
ENSG00000169756,LIMS1,cell adhesion,epithelial-to-mesenchymal transition,pi3k/akt pathway interaction,cancer cell invasion,protein-protein interactions,poor prognosis biomarker
ENSG00000072110,ACTN1,cell migration,cytoskeleton remodeling,metastatic potential,adhesion complex formation,invasion mechanisms,poor prognosis marker
ENSG00000091409,ITGA6,cell adhesion disruption,laminin-5 binding,tumor progression enhancement,migratory pathway activation,metastasis facilitation,egfr interaction
ENSG00000132470,ITGB4,tumor progression,cell adhesion disruption,metastasis promotion,ecm interaction,signaling pathway modulation,tumor-stroma interaction
ENSG00000196776,CD47,cd47 immune evasion,tumor microenvironment modulation,prognostic biomarker,therapeutic target,cell adhesion and migration regulation,signal regulatory protein alpha interaction
ENSG00000198053,SIRPA,altered expression,tumor microenvironment,immune evasion,angiogenesis promotion,tumor progression,phagocytic activity enhancement
ENSG00000089012,SIRPG,tumor cell migration,cell surface glycoprotein,immune modulation,complement regulation,adhesion molecule function,prognostic marker
ENSG00000161270,NPHS1,cell polarity disruption,cellular adhesion regulation,glomerular filtration barrier maintenance,podocyte function regulation,tumor progression promotion,cell signaling pathway modulation
ENSG00000183853,KIRREL1,microtubule regulation,cell-cell adhesion disruption,signaling pathway dysregulation,tumor progression facilitation,metastatic potential enhancement,emt process modulation
ENSG00000118898,PPL,oncogenic protein,cell proliferation,metastasis driver,prognostic marker,tumor aggressiveness,signal transduction modulator
ENSG00000167880,EVPL,membrane trafficking,cellular homeostasis,apoptosis regulation,autophagy modulation,tumor progression,genomic instability
ENSG00000189337,KAZN,genomic instability,transcriptional regulation,cell proliferation,apoptosis dysregulation,chromatin remodeling,therapeutic target
ENSG00000167754,KLK5,tumor progression,metastasis promotion,epithelial cell expression,serine protease activity,par/mmp activation,biomarker potential
ENSG00000133710,SPINK5,loss of function mutations,tumor suppressor activity,cellular proliferation regulation,desquamation regulation,kallikrein-related peptidase inhibition,skin barrier disruption
ENSG00000186474,KLK12,proteolytic activity,cell proliferation,overexpression,signaling pathway activation,metastasis regulation,epithelial-to-mesenchymal transition
ENSG00000178172,SPINK6,oncogene function,cell proliferation enhancement,apoptosis inhibition,epithelial-to-mesenchymal transition,pi3k/akt pathway activation,signaling pathway modulation
ENSG00000167759,KLK13,tumor progression,proteolytic activity,biomarker overexpression,metastatic potential,cellular proliferation,signaling pathway interaction
ENSG00000129437,KLK14,tumor progression,extracellular matrix degradation,cell migration and invasion,biomarker expression,protease activity,signaling molecule interaction
ENSG00000204909,SPINK9,angiogenic factor,oncogenesis promotion,tumor growth facilitation,metastatic pathway activation,poor prognostic marker,cancer progression driver
ENSG00000077782,FGFR1,fgfr signaling pathway,constitutive activation of downstream pathways,oncogenic driver,cell proliferation and survival,tumor invasion and metastasis,epithelial-to-mesenchymal transition (emt)
ENSG00000011201,ANOS1,androgen receptor regulation,coactivator function,tumor progression modulator,prostate cell differentiation,transcriptional activation enhancer,genetic expression regulator
ENSG00000165029,ABCA1,tumor suppressor,regulation of lipid metabolism,cellular growth inhibition,apoptosis induction,cholesterol efflux regulation,autophagy modulation
ENSG00000118137,APOA1,altered lipid profiles,modulation of immune response,immune cell activity,inflammation regulation,anti-inflammatory effects,lipid metabolism disruption
ENSG00000132855,ANGPTL3,metabolic reprogramming,angiogenesis promotion,tumor growth promotion,energy homeostasis regulation,lipid metabolism inhibition,aerobic glycolysis enhancement
ENSG00000130173,ANGPTL8,tumor growth promotion,interaction with pi3k/akt pathway,metabolic regulation alteration,angiogenesis facilitation,overexpression in cancer cells,biomarker for disease progression
ENSG00000126261,UBA2,genomic instability,dna repair deficiency,protein degradation regulation,oncogenic protein accumulation,tumor aggressiveness marker,ubiquitination pathway dysregulation
ENSG00000142230,SAE1,protein degradation regulation,cancer cell survival,dna damage response disruption,ubiquitin transfer dysfunction,cell cycle progression alteration,oncogenic protein accumulation
ENSG00000112576,CCND3,cell cycle regulation,oncogenic function,cell proliferation,tumor growth,prognostic marker,pi3k/akt interaction
ENSG00000069956,MAPK6,erk pathway activation,g2/m phase regulation,cell proliferation modulation,therapeutic target,phosphorylation-dependent activity,signaling pathway crosstalk
ENSG00000005884,ITGA3,oncogenic signaling,epithelial-to-mesenchymal transition,cell migration,tumor progression,prognostic marker,metastasis
ENSG00000135424,ITGA7,integrin signaling,loss of function mutations,cell adhesion disruption,metastasis facilitation,tumor progression,epithelial-to-mesenchymal transition
ENSG00000164171,ITGA2,integrin activation,cell adhesion regulation,tumor metastasis promotion,prognostic marker upregulation,cell migration enhancement,extracellular matrix interaction
ENSG00000213949,ITGA1,altered cell adhesion,constitutive activation,emt induction,gain of function mutations,integrin-mediated signaling,oncogenic potential
ENSG00000182220,ATP6AP2,metabolic regulation,enhanced cell growth,cellular ph homeostasis,tumor progression,oncogenic protein interaction,cell migration and invasion
ENSG00000143839,REN,tumor progression,genetic variation,cellular differentiation,transcriptional regulation,protein-protein interaction,apoptosis modulation
ENSG00000117481,NSUN4,oxphos disruption,metabolic reprogramming,glycolytic shift,cellular proliferation,mitochondrial biogenesis,chromatin regulation
ENSG00000122085,MTERF4,mitochondrial function,dysregulated expression,tumor suppressor activity,mitochondrial translation regulation,cancer metabolism,genomic instability
ENSG00000259207,ITGB3,tumor progression,cell adhesion,signaling pathway modulation,metastasis,angiogenesis promotion,poor prognosis marker
ENSG00000005961,ITGA2B,integrin signaling pathway,cell adhesion molecule,tumor growth promotion,metastasis facilitation,prognostic marker,genomic instability
ENSG00000130164,LDLR,angiogenesis,lipid metabolism,promoter of metastasis,tumor growth,survival factor,cholesterol regulation
ENSG00000169174,PCSK9,wnt/β-catenin pathway modulation,cholesterol metabolism regulation,tumor growth promotion,cancer metastasis facilitation,cell proliferation enhancement,angiogenesis induction
,TMEM173,immune regulation,tumor immunosuppression,type i ifn response,dna sensing,cancer immunoevasion,antiviral signaling
ENSG00000183735,TBK1,nf-κb pathway activation,gain of function mutations,tumor progression,oncogenic driver,cell proliferation regulation,dna repair regulation
ENSG00000139193,CD27,cell signaling,gene expression,t-cell activation,immune response regulation,anti-tumor immunity,protein interaction
ENSG00000125726,CD70,immunoregulation,overexpression,cell proliferation,tumor growth,immune evasion,genomic instability
ENSG00000135960,EDAR,signaling pathway modulation,receptor-ligand interaction,cell proliferation regulation,apoptosis inhibition,epithelial cell differentiation,oncogenic signaling activation
ENSG00000158813,EDA,epithelial cell development,tumor cell invasion,metastatic progression,notch pathway interaction,wnt/β-catenin pathway regulation,poor prognosis predictor
ENSG00000131080,EDA2R,overexpression,epidermal growth factor receptor interaction,cell migration enhancement,tumor aggressiveness predictor,pi3k/akt pathway activation,metastasis promoter
ENSG00000120337,TNFSF18,tumor progression,immunosuppressive microenvironment,nf-κb signaling pathway,t cell regulation,metastasis promotion,cell death modulation
ENSG00000186891,TNFRSF18,nf-κb activation,apoptosis regulation,tumor progression,cell survival promotion,protein interaction,oncogenic signaling
ENSG00000186827,TNFRSF4,programmed cell death regulation,tumor progression promotion,immune response modulation,t-cell activation enhancement,malignant transformation facilitation,apoptosis evasion
ENSG00000117586,TNFSF4,cell signaling pathway modification,immune system dysregulation,oncogenic transformation,tumor microenvironment modulation,cancer metastasis promotion,therapeutic target for autoimmune diseases
ENSG00000215788,TNFRSF25,tumor progression,tweak ligand activation,signaling pathway regulation,immune response modulation,apoptosis dysregulation,cancer therapeutic target
ENSG00000181634,TNFSF15,apoptosis regulation,tumor necrosis factor family member,immune response modulation,inflammation induction,cell death signaling,therapeutic target
ENSG00000106952,TNFSF8,tumor suppression,immune regulation,apoptosis induction,cancer cell elimination,biomarker potential,downregulated expression
ENSG00000120949,TNFRSF8,anti-tumor immunity,enhanced t-cell activation,costimulatory molecule,immune cell recruitment,tumor progression,immunotherapy target
ENSG00000125657,TNFSF9,tnf family signaling,inflammation regulation,cell proliferation modulation,tumor progression factor,cytokine release,immune cell interaction
ENSG00000049249,TNFRSF9,immune checkpoint,t cell modulation,cellular proliferation,pro-inflammatory signaling,malignant progression,therapeutic target
ENSG00000101213,PTK6,epithelial-to-mesenchymal transition,oncogenic signaling pathway,phosphorylation regulation,cell migration promotion,transcription factor modulation,growth factor receptor activation
ENSG00000121774,KHDRBS1,oncogenic driver,cell proliferation,apoptosis suppression,spliceosome complex,prognostic marker,rna-binding protein function
ENSG00000186635,ARAP1,gef regulation,cytokeleton reorganization,cell migration promoter,metastasis driver,oncogenic pathway interaction,pten/p53 regulatory complex
ENSG00000142208,AKT1,pi3k/akt signaling pathway,oncogenic driver mutations,cell survival and proliferation,therapeutic target,resistance to apoptosis,protein kinase activation
ENSG00000115325,DOK1,regulation of ptx activity,dysregulation of cell growth,modulation of signaling cascades,protein tyrosine kinase activation,interaction with oncogenes,tumor progression
ENSG00000196396,PTPN1,cell signaling regulation,tumor suppressor function,tyrosine phosphatase activity,oncogene inhibition,cancer metastasis suppression,genomic instability prevention
ENSG00000178078,STAP2,pi3k/akt pathway interaction,tumor progression promotion,protein stability alteration,metastasis facilitation,brca1 interaction,cell migration regulation
ENSG00000184557,SOCS3,jak/stat pathway regulation,tumor suppressor function,cytokine signaling modulation,apoptosis regulation,immune microenvironment regulation,growth factor response suppression
ENSG00000143127,ITGA10,cell adhesion,metastasis promotion,tumor progression,angiogenesis enhancement,rhoa/pi3k interaction,therapeutic target
ENSG00000275931,GP6,epithelial-to-mesenchymal transition,overexpression/amplification,tumor progression,cell adhesion regulation,oncogenic signaling,integrin interaction
ENSG00000132155,RAF1,mapk/erk signaling,constitutive activation,gain of function mutations,tumor progression,therapeutic target,signaling pathway modulation
ENSG00000164924,YWHAZ,cell cycle regulation,oncogenic processes,pi3k/akt signaling pathway modulation,apoptosis evasion,transcriptional regulation,protein-protein interactions
ENSG00000162493,PDPN,angiogenesis promotion,cell adhesion regulation,immune response modulation,metastasis facilitation,tumor progression marker,vegf interaction
ENSG00000165682,CLEC1B,immune modulation,tumor microenvironment regulation,metastatic progression,poor prognosis biomarker,cell adhesion mediator,pathogen recognition protein
ENSG00000197461,PDGFA,angiogenic factor,cell migration,cell proliferation,oncogene activation,receptor interaction,tumor progression
ENSG00000100311,PDGFB,proliferation,growth factor signaling,tumor progression,metastasis,angiogenesis,therapeutic target
ENSG00000169896,ITGAM,integrin signaling pathway,epithelial-to-mesenchymal transition,cell adhesion disruption,immune evasion mechanisms,proteolytic enzyme regulation,tumor microenvironment modulation
ENSG00000160255,ITGB2,integrin signaling pathway,cell migration,tumor progression,therapeutic resistance,biomarker potential,genomic alterations
ENSG00000154721,JAM2,cell migration,tumor progression,metastasis,adhesion molecule regulation,immune response modulation,cell invasion
ENSG00000166086,JAM3,cell-cell adhesion disruption,tumor progression,metastasis promotion,poor prognosis marker,pi3k/akt pathway interaction,angiogenesis regulation
ENSG00000115232,ITGA4,epithelial-to-mesenchymal transition,adhesion molecule regulation,angiogenesis facilitation,metastasis promotion,cell migration enhancement,protein-protein interaction
ENSG00000005844,ITGAL,epithelial-to-mesenchymal transition,immune evasion mechanism,cell adhesion molecule,tumor microenvironment modulation,signal transduction pathway activation,metastasis promotion
ENSG00000140678,ITGAX,integrin signaling,cell adhesion regulation,tumor progression facilitation,metastasis promotion,epithelial-to-mesenchymal transition,immune response modulation
ENSG00000117091,CD48,immune modulation,cell-cell interactions,tumor immunity evasion,cytokine regulation,chemokine expression,immunosuppressive environment
ENSG00000122223,CD244,nk cell activation,tumor progression,immune modulation,genetic amplification,signaling pathway regulation,adhesion molecule interaction
ENSG00000116815,CD58,immune evasion,tumor progression,metastasis,prognostic marker,cell surface interaction,adhesion molecules
ENSG00000116824,CD2,t-cell activation,cell adhesion modulation,oncogenic processes,signaling pathway involvement,immune system regulation,cancer immunosurveillance
ENSG00000161638,ITGA5,tumor progression,upregulation of expression,cell adhesion modulation,metastasis enhancement,angiogenesis promotion,oncogenic signaling pathways activation
ENSG00000160593,JAML,jak/stat pathway regulation,cell adhesion facilitation,epigenetic regulation,microenvironment interaction,oncogenic signaling,tumor progression facilitation
ENSG00000154639,CXADR,cell-cell adhesion disruption,epithelial-to-mesenchymal transition,immune evasion,integrin interaction,metastasis promotion,tumor progression
ENSG00000240972,MIF,oncogene,promotes tumor growth,dna repair mechanism,immunosuppression,therapeutic target,genomic instability
ENSG00000019582,CD74,tumor progression,metastasis promotion,immune evasion,cell migration,prognostic biomarker,mhc class ii expression
ENSG00000120156,TEK,vegf signaling,tumor neovascularization,angiogenic processes,vascular development,receptor tyrosine kinase activation,endothelial cell migration
ENSG00000154188,ANGPT1,vascular remodeling,angiogenic signaling,oncolytic function,tumor metastasis,vegf pathway interaction,endothelial cell regulation
ENSG00000091879,ANGPT2,angiogenic factor,endothelial cell migration,poor prognosis marker,tumor progression,metastasis regulation,transcriptional activation
ENSG00000101280,ANGPT4,angiogenesis promotion,epithelial-to-mesenchymal transition,pro-angiogenic environment,tumor vascularization,endothelial cell permeability,vegf/vegfr pathway interaction
ENSG00000168918,INPP5D,regulation of immune function,inhibitory receptor signaling,cell proliferation regulation,tumor growth promotion,apoptosis modulation,metastasis facilitation
ENSG00000124181,PLCG1,constitutive activation,gain of function mutations,tumor progression,cell proliferation,protein kinase activation,signaling pathway regulation
ENSG00000172270,BSG,cell migration enhancement,cancer progression,signaling pathway regulation,tumor invasion facilitation,immune function modulation,adhesion molecule function
ENSG00000100023,PPIL2,cell cycle regulation,protein phosphatase activity,dna repair mechanism,brca1 interaction,gain of function mutations,microtubule dynamics
ENSG00000105974,CAV1,caveolae disruption,cell signaling deregulation,tumor suppressor function,pi3k/akt pathway modulation,cellular homeostasis disruption,protein-protein interaction alteration
ENSG00000196262,PPIA,cellular regulation,dna repair mechanisms,protein folding regulation,tumor progression,angiogenesis promotion,cell cycle regulation
ENSG00000155465,SLC7A7,amino acid transport,cell proliferation,enhanced metabolic activity,tumor microenvironment modulation,epigenetic regulation,protein overexpression
ENSG00000168003,SLC3A2,cellular growth,metabolic regulation,tumor progression,gene expression regulation,protein-protein interaction,transmembrane transport
ENSG00000092068,SLC7A8,l-amino acid transport,tumor metabolism regulation,cellular uptake modulation,therapeutic target,aggressive tumor phenotype promotion,poor prognosis association
ENSG00000021488,SLC7A9,amplification,amino acid transport,oncogenic driver,mammalian target of rapamycin (mtor) pathway activation,cell proliferation,tumor aggressiveness
ENSG00000151012,SLC7A11,metabolic regulation,oxidative stress resistance,tumor growth promotion,cancer stem cell maintenance,therapeutic target,redox balance regulation
ENSG00000103257,SLC7A5,cellular homeostasis,amino acid transport,promoting cell proliferation,survival enhancement,cancer progression,malignant potential
ENSG00000130876,SLC7A10,cellular metabolism regulation,tumor progression promotion,oncogenic protein interaction,amino acid transport facilitation,therapeutic target potential,poor prognosis indicator
ENSG00000103064,SLC7A6,mtor pathway regulation,amino acid transport,oncogenic metabolic reprogramming,cellular homeostasis disruption,tumor microenvironment modulation,genomic instability promotion
ENSG00000136750,GAD2,glutamate decarboxylation,gaba signaling pathway,tumor aggressiveness,cellular proliferation,biomarker potential,neurotransmitter regulation
ENSG00000128683,GAD1,gabaergic system regulation,metabolic reprogramming,cell survival promotion,apoptosis inhibition,tumor progression marker,neurotransmitter function modulation
ENSG00000186090,HTR3D,breast cancer association,gastrointestinal motility regulation,neurotransmitter release modulation,serotonin receptor function,receptor subunit interaction,tissue expression variation
ENSG00000166736,HTR3A,oncogene potential,apoptosis regulation,cell migration modulation,signaling pathway interaction,cancer stem cell regulation,ion channel function
ENSG00000186038,HTR3E,histamine signaling pathway,cell proliferation regulation,ligand-gated chloride channel function,tumor progression,overexpressed in cancer cells,pi3k/akt pathway activation
ENSG00000149305,HTR3B,serotonin signaling pathway,cell proliferation,epithelial-to-mesenchymal transition,overexpression,neurotransmitter release,ligand-gated ion channel
ENSG00000178084,HTR3C,oncogene,tumor aggressiveness,cell proliferation,signaling pathway modulation,cellular survival,serotonin receptor function
ENSG00000175387,SMAD2,tgf-β signaling pathway,transcriptional regulation,dysregulation in tumor progression,cell proliferation regulator,metastasis mediator,genomic instability marker
ENSG00000177628,GBA,lysosomal function,oxidative stress modulation,tumor microenvironment remodeling,immune response regulation,cancer risk modifier,autophagy dysregulation
ENSG00000197746,PSAP,lipid biosynthesis,cellular homeostasis,membrane biogenesis,glycosphingolipids,protein-lipid interactions,therapeutic target
ENSG00000112799,LY86,immune response modulation,tumor progression,metastasis promotion,biomarker potential,cell signaling regulation,cancer stem cell maintenance
ENSG00000134061,CD180,traf3ip2 interaction,nf-κb signaling,tumor proliferation,pro-survival signaling,immune evasion,cancer prognosis
ENSG00000118004,COLEC11,tumor microenvironment modulation,inflammation regulation,immune evasion mechanism,cell migration promotion,angiogenesis activation,prognostic biomarker
ENSG00000127241,MASP1,lectin pathway,proteolytic activity,complement system activation,cell proliferation regulation,tumor progression factor,metastasis promotion
ENSG00000169562,GJB1,connexin function,cellular communication disruption,epithelial cell involvement,intercellular signaling modulation,potential oncogenic implications,limited breast cancer association
ENSG00000165474,GJB2,disrupted gap junctions,tumor aggressiveness,cellular communication,chemotherapy resistance,stress response regulation,potential oncogene partner
ENSG00000152661,GJA1,gap junctional communication,cellular adhesion,dna damage response,genomic stability,cell proliferation regulation,intercellular communication
ENSG00000277401,TJP1,tight junction disruption,cell-cell adhesion loss,pi3k/akt pathway regulation,epithelial barrier permeability,oncogenic transformation,interaction with emt regulators
ENSG00000069869,NEDD4,cell signaling regulation,protein degradation pathway,ubiquitination activity,tumor progression marker,therapeutic target for resistance,genomic stability regulator
ENSG00000138032,PPM1B,tumor suppressor,dephosphorylation activity,dna repair regulation,genomic stability maintenance,apoptosis induction,therapeutic target
ENSG00000136068,FLNB,cell migration,cytoskeletal regulation,tumor progression,genetic mutation,protein-protein interaction,oncogenesis
ENSG00000137033,IL33,tumor-promoting inflammation,overexpression in tumors,enhances cell proliferation,nf-κb pathway activation,immunomodulation through stat6 interaction,therapeutic target for immune modulation
ENSG00000115602,IL1RL1,angiogenesis facilitation,tumor microenvironment modulation,oncogenic potential,metastasis promotion,epithelial-to-mesenchymal transition,immunosuppression facilitation
ENSG00000125571,IL37,anti-inflammatory cytokine,immune evasion,angiogenesis promotion,tumor progression,inflammation regulation,prognostic marker
ENSG00000100368,CSF2RB,il-3r signaling,jak/stat pathway activation,cell proliferation modulation,cancer cell survival enhancement,tumor growth promotion,genetic alterations
ENSG00000198223,CSF2RA,tumor progression,genomic instability,cell migration,angiogenesis promotion,immunosuppression,hematopoietic cell regulation
ENSG00000164400,CSF2,gm-csf signaling,tumor progression,immune evasion,angiogenesis,myeloid cell recruitment,pro-inflammatory environment
ENSG00000091181,IL5RA,immune modulation,promotion of tumor growth,pro-inflammatory cytokine induction,therapeutic target,signaling pathway activation,tumor microenvironment modification
ENSG00000113525,IL5,**
eosinophil activation,cell proliferation regulation,growth factor signaling,immune microenvironment modulation,poor prognosis marker,tumor progression facilitation
**
,TEC,t-cell signaling,leukocyte activation,kinase activity,immune cell regulation,signaling pathway modulation,cell proliferation
ENSG00000141968,VAV1,cell migration,rho gtpases regulation,cytoskeletal reorganization,tumor progression,oncogenesis,signaling pathway modulation
ENSG00000095585,BLNK,signaling pathway dysregulation,cell proliferation enhancement,tyrosine kinase interaction,scaffold protein function,oncogenic potential,poor prognosis marker
ENSG00000077238,IL4R,immune evasion,cell proliferation,signal transduction,tumor progression,transmembrane receptor,gene expression regulation
ENSG00000131724,IL13RA1,angiogenesis promotion,cell proliferation enhancement,immune suppression,tumor progression facilitation,epithelial-to-mesenchymal transition regulation,metastasis enhancement
ENSG00000169194,IL13,tumor microenvironment modulation,constitutive overexpression,epithelial-to-mesenchymal transition,cellular proliferation enhancement,angiogenesis promotion,immune suppressive cell recruitment
ENSG00000123496,IL13RA2,oncogenic function,tumor progression,immune suppression,protein-protein interaction,cell proliferation regulation,signal transduction
ENSG00000168685,IL7R,il-7 signaling,immune evasion,cell proliferation,tumor microenvironment modulation,proliferation and survival signals,aberrant activation pathways
ENSG00000127616,SMARCA4,chromatin remodeling,tumor suppressor function,dna repair disruption,synthetic lethality,oncogenic pathway activation,swi/snf complex dysfunction
ENSG00000185658,BRWD1,dna damage response,chromatin remodeling,transcriptional regulation,genomic instability,histone modification,tumor suppressor function
ENSG00000164485,IL22RA2,tumor microenvironment modulation,immune suppression,ligand dysfunction,cell survival promotion,breast cancer progression,prognostic marker
ENSG00000127318,IL22,pro-inflammatory activity,tumor-promoting activities,immune modulation,cell proliferation regulation,cytokine signaling pathway,inflammation regulation
ENSG00000185436,IFNLR1,immune evasion,tumor microenvironment modulation,inflammation regulation,antiviral response activation,cell proliferation suppression,apoptosis induction
ENSG00000172349,IL16,tumor progression,immune evasion,protein interaction,signaling pathway dysregulation,cytokine overexpression,metastatic potential
ENSG00000008517,IL32,inflammation promotion,tumor growth enhancement,pro-inflammatory mediator induction,angiogenesis facilitation,cancer cell proliferation,immune response modulation
ENSG00000196415,PRTN3,tumor progression,proteolytic activation,apoptosis regulation,cell migration,metastasis,cellular signaling
ENSG00000122025,FLT3,oncogenic mutation,constitutive activation,signaling pathway regulation,cell growth promotion,tumor progression,therapeutic target
ENSG00000090554,FLT3LG,tumor microenvironment modulation,metastasis promotion,cell proliferation enhancement,angiogenesis facilitation,poor prognosis indicator,receptor interaction
ENSG00000108342,CSF3,oncogenic properties,enhanced cell proliferation,angiogenesis,receptor interaction,signaling pathway alterations,mutation/expression alteration
ENSG00000119535,CSF3R,myeloid cell regulation,tyrosine kinase activation,constitutive activation,growth factor receptor signaling,cell proliferation,signaling pathway dysregulation
ENSG00000084652,TXLNA,pi3k/akt signaling pathway modulation,cell proliferation enhancement,apoptosis resistance,aggressive tumor behavior,oncogenic potential,therapeutic target
ENSG00000106089,STX1A,cell-cell interactions,tumor growth modulation,gene expression regulation,cancer cell migration,snare protein interaction,vesicle fusion regulation
ENSG00000112964,GHR,growth hormone signaling,jak/stat activation,cell proliferation enhancement,inflammatory response modulation,immune evasion mechanism,tumor progression facilitation
ENSG00000113494,PRLR,prolactin-mediated signaling,oncogenic activation,gain of function mutations,tumor progression,therapeutic target,cellular proliferation
ENSG00000131323,TRAF3,genomic instability,tumor suppressor function,constitutive activation,nf-κb pathway regulation,apoptosis resistance,dna repair modulation
ENSG00000028137,TNFRSF1B,aberrant nf-κb signaling,loss of function mutations,enhanced tumor growth,apoptosis regulation,immune evasion mechanism,tumor suppressor role
ENSG00000102245,CD40LG,tumor suppression,apoptosis induction,cancer immunity modulation,cell growth regulation,nf-κb signaling pathway activation,immune cell activation
ENSG00000101017,CD40,tumor immunity regulation,co-stimulatory molecule function,immune cell recruitment,antitumor responses modulation,oncogenic potential,nf-kappa b pathway activation
ENSG00000159958,TNFRSF13C,tnf receptor signaling,immune modulation,tumor microenvironment modification,b-cell activation regulation,proliferation enhancement,cytokine production modulation
ENSG00000102524,TNFSF13B,tumor necrosis factor superfamily member,immune evasion,immunosuppressive microenvironment,cell death regulation,tumor growth promotion,poor prognosis
ENSG00000076641,PAG1,pi3k/akt pathway regulation,cell proliferation enhancement,oncogenic signaling modulation,protein kinase activation involvement,altered subcellular distribution,tumor progression facilitation
ENSG00000103653,CSK,src family kinases inhibition,stat3 activation,pi3k/akt pathway,cell proliferation enhancement,e-cadherin regulation,oncogenic signaling modulation
ENSG00000134242,PTPN22,aberrant t-cell signaling,constitutive activation,gain of function mutations,immune evasion,oncogenesis,tumor cell survival
ENSG00000213658,LAT,signaling pathway alteration,immune evasion mechanisms,tumor microenvironment modulation,cell proliferation enhancement,adaptive immunity suppression,genetic mutations leading to oncogenic transformation
ENSG00000082074,FYB1,cell cycle progression,tumor suppressor interaction,protein kinase activation,oncogenic signaling,breast cancer subtype,phosphorylation regulation
ENSG00000158092,NCK1,cell migration,adaptor protein function,gtpase regulation,cell invasion,epithelial-to-mesenchymal transition,prognostic marker
ENSG00000135341,MAP3K7,cell survival pathway,inflammation activation,oncogenic signaling,apoptosis inhibition,tumor growth promotion,genomic instability
ENSG00000055208,TAB2,nf-κb pathway activation,tak1 complex interaction,cell survival promotion,brca1 regulation,genomic instability induction,pro-survival signaling enhancement
ENSG00000163600,ICOS,t cell activation,costimulation,immune evasion,enhanced proliferation,prognostic biomarker,immune response modulation
ENSG00000160223,ICOSLG,t-cell activation,immune evasion,oncogenesis,immune suppression,prognostic marker,genomic instability
ENSG00000157873,TNFRSF14,tumor progression,pro-survival signaling pathways,constitutive activation,immune modulation,gene mutation,tumor-promoting activity
ENSG00000186265,BTLA,immune evasion,t cell suppression,inhibitory receptor function,modulation of immune responses,cancer immunoediting,regulatory t cells interaction
ENSG00000121594,CD80,immune evasion,t-cell modulation,angiogenesis promotion,metastatic progression,pi3k/akt pathway regulation,cell adhesion molecule modulation
ENSG00000178562,CD28,immune evasion,co-stimulation,t-cell activation,proliferation,survival,tumor microenvironment
ENSG00000114013,CD86,t-cell activation,co-stimulation mechanism,protein-protein interaction,immune evasion strategy,tumor microenvironment modulation,breast cancer prognosis
ENSG00000100906,NFKBIA,nf-κb signaling pathway,dysregulated tumor suppressor,tumor cell survival,apoptosis resistance,proliferation enhancement,therapeutic target
ENSG00000141367,CLTC,endocytosis regulation,tumor heterogeneity,cell survival enhancement,signaling pathway modulation,apoptosis dysregulation,proliferation promotion
ENSG00000122705,CLTA,clathrin-mediated endocytosis,oncogene,upregulated expression,signaling pathway regulation,epithelial cell transformation,cellular localization changes
ENSG00000242574,HLA-DMB,tumor microenvironment,immune evasion,antigen presentation,prognostic marker,therapeutic target,genomic instability
ENSG00000204257,HLA-DMA,antigen presentation,immune evasion,non-classical mhc class i,cd8+ t cell interaction,tumor immunology,immunogenicity
ENSG00000153283,CD96,tumor-associated antigen,immune checkpoint molecule,metastasis promotion,cell adhesion modulation,pi3k/akt pathway regulation,therapeutic target
ENSG00000139626,ITGB7,cell adhesion regulation,metastasis promotion,tumor progression,signaling pathway activation,angiogenesis facilitation,cancer stem cell maintenance
ENSG00000206493,HLA-E,tumor immune evasion,immune suppression,antigen presentation,mhc class i molecule,cancer progression,immunotherapy target
ENSG00000039068,CDH1,loss-of-function mutations,tumor suppression,disrupted cell-cell adhesion,increased cellular invasion,cellular migration regulation,apical-basal polarity disruption
ENSG00000139187,KLRG1,oncogenic function,tumor progression,immune evasion,cell proliferation suppression,poor prognosis indicator,immune modulation
ENSG00000150637,CD226,tumor progression,immune modulation,pro-tumoral microenvironment,biomarker for treatment response,cell adhesion regulation,inflammation-mediated upregulation
ENSG00000091972,CD200,tumor microenvironment modulation,immune suppression,myeloid cell interaction,poor prognosis marker,cell surface protein,immunosuppressive activity
ENSG00000163606,CD200R1,**

* tumor immune evasion,* immune suppression,* tumor progression,* antitumor immunity modulation,* immunoregulatory receptor,* itim-mediated signaling 

**
ENSG00000235346,HLA-G,tumor immune evasion,immune regulation,poor prognosis,aggressive tumor progression,angiogenesis promotion,epigenetic regulation
ENSG00000275583,KIR2DS2,regulation of cell proliferation,interaction with other proteins,signaling pathway modulation,tumor progression correlation,apoptosis regulation,potassium channel function
ENSG00000069493,CLEC2D,tumor progression,cell adhesion modulation,protein-protein interactions,immune response regulation,metastasis promotion,epigenetic regulation
ENSG00000111796,KLRB1,tumor cell invasion,immune evasion,ligand binding,cancer progression,metastasis,prognostic marker
ENSG00000158125,XDH,purine metabolism,redox balance,metabolic reprogramming,reactive oxygen species production,angiogenesis regulation,tumor microenvironment modulation
ENSG00000124557,BTN1A1,epigenetic regulation,chromatin remodeling,cell proliferation,genomic instability,apoptosis resistance,dna repair mechanism
ENSG00000115221,ITGB6,integrin-ecm interaction,pro-tumorigenic microenvironment,cell migration and invasion,tumor progression,therapeutic target,growth factor regulation
ENSG00000105329,TGFB1,tumor suppressor activity,epithelial-to-mesenchymal transition (emt) regulation,oncogenic potential,angiogenesis promotion,metastasis facilitation,immune suppression
ENSG00000090006,LTBP4,tumor progression,basement membrane assembly,cell adhesion modulation,angiogenesis regulation,cell migration enhancement,extracellular matrix interaction
ENSG00000077943,ITGA8,integrin alpha 8 subunit,cell adhesion modulation,metastasis promotion,tumor progression,angiogenesis regulation,cell migration facilitation
ENSG00000105855,ITGB8,integrin adhesion,tumor progression,epithelial-to-mesenchymal transition (emt),cell migration,sigaling pathway activation,protein-ligand interaction
ENSG00000064692,SNCAIP,microtubule dynamics,cell migration,tumor invasion,stable microtubules,cell cycle regulation,oncogenic function
ENSG00000185345,PRKN,mitochondrial autophagy,cell survival regulation,tumor suppressor function,mitochondrial damage accumulation,oxidative stress induction,genomic instability
ENSG00000145335,SNCA,cell adhesion disruption,metastasis promotion,cytoskeletal alterations,cell migration enhancement,tumor aggressiveness promoter,stress response modulation
ENSG00000124486,USP9X,deubiquitination activity,oncogene function,protein stabilization,cell cycle progression,apoptosis evasion,tumor aggressiveness
ENSG00000137642,SORL1,tumor suppressor function,intracellular trafficking regulation,aberrant expression in cancer,cellular process regulation,prognostic biomarker potential,autophagy and endocytosis involvement
ENSG00000142192,APP,aggressive tumor behavior,apoptosis inhibition,cell proliferation enhancement,neurofibrillary tangle formation,pi3k/akt pathway modulation,wnt/β-catenin signaling regulation
ENSG00000145782,ATG12,autophagy regulation,dysregulated function,tumor suppressor,cellular recycling,growth factor regulation,loss-of-function mutations
